<?xml version="1.0"?> 
<rss version="2.0">

	<channel>
		<title>Natural Health Trends Corp. - C (NHTC) research, news, and more from GeoInvesting</title>
		<description>The latest research, news, and more from GeoInvesting for Natural Health Trends Corp. - C (NHTC)</description>
		<link>/companies/nhtc_natural_health_trends_corp____c/overview</link>
		<language>en-us</language>
		<pubDate>Thu, 30 Apr 2026 08:51:22 GMT</pubDate>
		<lastBuildDate>Thu, 30 Apr 2026 08:51:22 GMT</lastBuildDate>
        <ttl>120</ttl>
        
        <item><title>Company description</title><guid isPermaLink="false">33630</guid><pubDate>Wed, 05 Mar 2008 05:00:00 GMT</pubDate><description>&lt;FONT size=2&gt;Natural Health Trends Corp. is an international direct-selling and e-commerce company operating through its subsidiaries throughout &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;Asia&lt;/SPAN&gt;, North America, and Europe. The company markets premium quality personal care products under the NHT Global brand.&lt;/FONT&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/overview</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">60914</guid><pubDate>Tue, 05 May 2020 04:00:00 GMT</pubDate><description>&lt;P style=&apos;FONT-SIZE: 13px; FONT-FAMILY: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(51,51,51); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial&apos;&gt;&lt;A style=&quot;COLOR: rgb(7,130,193)&quot; href=&quot;https://www.globenewswire.com/news-release/2020/05/06/2028453/0/en/Natural-Health-Trends-Reports-First-Quarter-2020-Financial-Results.html&quot; data-cke-saved-href=&quot;https://www.globenewswire.com/news-release/2020/05/06/2028453/0/en/Natural-Health-Trends-Reports-First-Quarter-2020-Financial-Results.html&quot;&gt;First Quarter&amp;nbsp;2020 Financial Results&lt;/A&gt;&lt;/P&gt;
&lt;UL style=&apos;FONT-SIZE: 13px; FONT-FAMILY: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(51,51,51); PADDING-BOTTOM: 0px; FONT-STYLE: normal; PADDING-TOP: 0px; PADDING-LEFT: 40px; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; PADDING-RIGHT: 40px; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial&apos;&gt;
&lt;LI&gt;Revenue of $14.9 million decreased 23% compared to $19.3 million in the first quarter of 2019.&lt;/LI&gt;
&lt;LI&gt;Net loss was $573,000, or $0.05 per diluted share, compared to a net loss of $1.9 million, or $0.17 per diluted share, in the first quarter of 2019.&lt;/LI&gt;&lt;/UL&gt;
&lt;P style=&apos;FONT-SIZE: 13px; FONT-FAMILY: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(51,51,51); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial&apos;&gt;&amp;#8220;First and foremost, our thoughts are with all of those around the world who have been impacted by the coronavirus,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &amp;#8220;I am pleased that we have continued to run our operations efficiently with the health and safety of our employees, members and customers guiding our decisions as our top priority. The impact of the pandemic followed the already difficult operating conditions we experienced throughout 2019. While we could have never foreseen the impact COVID-19 would have on the global economy, we focused our efforts in 2019 on preparing our business to adapt to new realities following China&amp;#8217;s 100-day campaign and have been applying key learnings from our experience to support our affected markets. To that end, we started implementing aggressive cost reduction measures beginning in the second half of 2019 which were partially offset by additional spending during the first quarter in direct response to COVID-19 and the governments&amp;#8217; measures to control the spread of the virus.&amp;nbsp; As a result of the net effect of these actions, we narrowed the scope of our first quarter operating loss and decline in cash flow from operations despite the fact that our main markets were under severe lockdown for most of first quarter of 2020.&amp;#8221;&lt;/P&gt;
&lt;P style=&apos;FONT-SIZE: 13px; FONT-FAMILY: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(51,51,51); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial&apos;&gt;Mr. Sharng concluded, &amp;#8220;We have ample liquidity with $95 million in cash and cash equivalents and zero debt. Further, our highly variable cost structure allows us the flexibility to adapt in-line with order volume. As previously announced, we put a program in place to position us for increased operating efficiencies in several areas including reducing headcount and promotional spending. As a result, we now expect to realize annualized cost savings of approximately $8 million in 2020. I feel confident our employees and members will work together through these unprecedented times with our support and that we will emerge from this downturn even stronger than before.&amp;#8221;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=60914</link></item><item><title>Regular Dividend News</title><guid isPermaLink="false">60915</guid><pubDate>Tue, 05 May 2020 04:00:00 GMT</pubDate><description>
&lt;P style=&apos;FONT-SIZE: 13px; FONT-FAMILY: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(51,51,51); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial&apos;&gt;HONG KONG, May 06, 2020&lt;SPAN&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;A style=&quot;COLOR: rgb(7,130,193)&quot; href=&quot;https://www.globenewswire.com/news-release/2020/05/06/2028453/0/en/Natural-Health-Trends-Reports-First-Quarter-2020-Financial-Results.html&quot; data-cke-saved-href=&quot;https://www.globenewswire.com/news-release/2020/05/06/2028453/0/en/Natural-Health-Trends-Reports-First-Quarter-2020-Financial-Results.html&quot;&gt;(GLOBE NEWSWIRE&lt;/A&gt;) -- Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and&amp;nbsp;&amp;#8220;quality of life&amp;#8221;&amp;nbsp;products under the NHT Global brand, today announced its financial results for the first quarter ended March&amp;nbsp;31, 2020.&lt;/P&gt;
&lt;P style=&apos;FONT-SIZE: 13px; FONT-FAMILY: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(51,51,51); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial&apos;&gt;&lt;BR&gt;&lt;/P&gt;
&lt;P style=&apos;FONT-SIZE: 13px; FONT-FAMILY: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(51,51,51); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial&apos;&gt;On May 4, 2020, the Company&amp;#8217;s Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on May 29, 2020 to stockholders of record as of May 19, 2020.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=60915</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">60648</guid><pubDate>Wed, 12 Feb 2020 05:00:00 GMT</pubDate><description>&lt;P&gt;&lt;A style=&quot;COLOR: rgb(7,130,193)&quot; href=&quot;https://www.globenewswire.com/news-release/2020/02/12/1983848/0/en/Natural-Health-Trends-Reports-Fourth-Quarter-and-Full-Year-2019-Financial-Results.html&quot; data-cke-saved-href=&quot;https://www.globenewswire.com/news-release/2020/02/12/1983848/0/en/Natural-Health-Trends-Reports-Fourth-Quarter-and-Full-Year-2019-Financial-Results.html&quot;&gt;Fourth Quarter&amp;nbsp;2019 Financial Results&lt;/A&gt;&lt;/P&gt;
&lt;UL style=&quot;PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 40px; PADDING-RIGHT: 40px&quot;&gt;
&lt;LI&gt;Revenue of $17.8 million decreased 57% compared to $41.6 million in the fourth quarter of 2018.&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;Net loss was $2.8 million, or $0.27 per diluted share, compared to net income of $5.6 million, or $0.49 per diluted share, in the fourth quarter of 2018.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;#8220;2019 was a challenging year for our business amid a host of macroeconomic and industry-specific factors that created a highly difficult operating environment,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &amp;#8220;In addition to China&amp;#8217;s 100 day campaign announced last January and negative sentiment stemming from social media as it relates to health products companies in China, additional developments such as ongoing global trade tensions, China&amp;#8217;s slowing economy and civil unrest in Hong Kong further contributed to the decline in revenue for 2019. That said, order volume in the fourth quarter of 2019 increased 12% over the prior quarter as a result of our successful event in Macau, along with a positive response to our various product promotions and incentives.&amp;#8221;&lt;/P&gt;
&lt;P&gt;Mr. Sharng further commented, &amp;#8220;While our first quarter results are typically affected by the Chinese New Year, the coronavirus outbreak and the unprecedented measures to control it are posing further challenges to the market. Following the extended Chinese New Year holidays, we plan to rely on product promotions and webcast training to overcome physical restrictions. We are continuing to monitor the evolving situation closely and will adapt our marketing programs accordingly. Looking ahead, we have implemented a strategy to more effectively manage elements within our control including: ensuring our incentives remain attractive to our leaders and member base; continuing to expand our operations into new geographies; and reducing our cost structure. To that end, we expect to achieve annualized cost savings of approximately $6.5 million in 2020.&amp;#8221;&lt;/P&gt;
&lt;P&gt;The Company expects to issue its 2019 audited financial results in March with its Annual Report on Form 10-K to be filed with the Securities and Exchange Commission. The financial results are preliminary and the accompanying financial statements have not been audited or have not yet been reviewed by the Company&amp;#8217;s independent accountants. Significant updates and revisions may be required before the release of the Company&amp;#8217;s 2019 audited financial results.&lt;/P&gt;
&lt;P&gt;&lt;BR style=&apos;FONT-SIZE: 13px; FONT-FAMILY: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(51,51,51); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(255,255,255); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial&apos;&gt;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=60648</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">59510</guid><pubDate>Fri, 01 Nov 2019 14:05:31 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;https://www.globenewswire.com/news-release/2019/11/01/1939498/0/en/Natural-Health-Trends-Reports-Third-Quarter-2019-Financial-Results.html&quot; target=_blank&gt;Third Quarter&amp;nbsp;2019 Financial Results&lt;/A&gt;&lt;/P&gt;
&lt;UL style=&quot;PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 40px; PADDING-RIGHT: 40px&quot;&gt;
&lt;LI&gt;Revenue of $17.0 million decreased 64% compared to $47.0 million in the third quarter of 2018.&lt;/LI&gt;
&lt;LI&gt;Net loss was $1.2 million, or $0.12 per diluted share, compared to net income of $7.6 million, or $0.67 per diluted share, in the third quarter of 2018.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;#8220;The business environment in China continued to present broad challenges during the third quarter,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &amp;#8220;In addition, protests in Hong Kong posed new complications. As a result, we suspended company-sponsored meetings in Hong Kong as current conditions are not conducive to hosting visitors.&amp;#8221;&lt;/P&gt;
&lt;P&gt;Mr. Sharng further commented, &amp;#8220;Beyond the elements that are not within our control, we remain pleased with our leaders&amp;#8217; abilities to adapt our business strategy and to continue performing under these circumstances. Subsequent to quarter end, we held a successful event in Macau which was traditionally held during the third quarter. Our fourth quarter order volume trends are already improving following this major event which is a promising development. Lastly, in light of the current business environment, we are implementing cost reduction measures to focus resources on our members and markets. We expect to realize an annualized $5.7 million in savings by the first quarter of 2020.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR style=&apos;FONT-SIZE: 13px; FONT-FAMILY: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(51,51,51); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(255,255,255); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial&apos;&gt;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=59510</link></item><item><title>Research</title><guid isPermaLink="false">58663</guid><pubDate>Tue, 07 May 2019 16:23:17 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trends_corp____c/overview&quot;&gt;&lt;STRONG&gt;Natural Health Trends Corp.&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt;&amp;nbsp;(NASDAQ:NHTC) ($11.96 $135.7M market cap),&lt;/STRONG&gt;&amp;nbsp;a direct-selling and e-commerce company that markets premium quality personal care, wellness, and &amp;#8220;quality of life&amp;#8221; products under the NHT Global brand, announced Q1 2019 results:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;P&gt;Sales of $19.3 million vs $52.4 million in the prior year&lt;/P&gt;
&lt;LI&gt;
&lt;P&gt;Net loss of $0.17 vs EPS $0.78 in the prior year&lt;/P&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;BLOCKQUOTE&gt;
&lt;P&gt;&quot;As we previously disclosed, in response to the Chinese government&apos;s announcement of its 100-day campaign in January, as was the case with many peer companies, we voluntarily suspended our member activities,&quot; commented Chris Sharng, President of Natural Health Trends Corp. &quot;The suspension covered more than 90% of the number of days in the first quarter, which also included the Chinese New Year holidays. We have made it our priority to fully cooperate with the government and to proactively ensure we continue to conduct our business in compliance with all applicable laws in China. While our financial performance was adversely impacted by this initiative during the quarter, we strongly support the actions taken by the Chinese government to root out bad products and deceptive practices in order to protect Chinese consumers.&quot;&lt;/P&gt;
&lt;P&gt;Mr. Sharng further commented, &quot;While the 100-day campaign expired in late April, there has been no official conclusion to end the program. We have great confidence in our ability to navigate the business through uncertain times and to renew growth once the macroclimate improves. While we are cautious as it relates to our overall performance for the remainder of 2019 given the uncertain trade and regulatory environment, we were pleased with the outcome of our successful major event in Hong Kong at the end of March and ongoing support of our market leaders. We were also thrilled to have launched NHT Global in India and remain encouraged by the continued growth we have been experiencing in Latin America, led by Peru.&quot;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;On January 7, 2019 we&amp;nbsp;&lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trends_corp____c/research/research/0067074&quot;&gt;discussed&lt;/A&gt;&amp;nbsp;that CCTV (China Central Television is the predominant state television broadcaster in China) aired an 18 minute&amp;nbsp;&lt;A  href=&quot;https://baijiahao.baidu.com/s?id=1621819555282197155&quot;&gt;program&lt;/A&gt;&amp;nbsp;that alleged NHTC was a pyramid scheme in China. Since the CCTV airing, we also highlighted the following developments:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;City of Harbin, China investigating to see if the company has any related business in its city 
&lt;LI&gt;Weak Q4 sales number, which was a result of business operations prior to negative press 
&lt;LI&gt;Most notably, the state industrial and commercial department (SAIC) of Beijing has officially launched an investigation into the company&amp;#8217;s Beijing office, which was confirmed by a reporter at the 21st Century Business Herald&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;We remain short a portion of our initial January position.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=58663</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">58653</guid><pubDate>Tue, 07 May 2019 13:30:34 GMT</pubDate><description>&lt;P style=&apos;FONT-SIZE: 13px; FONT-FAMILY: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(51,51,51); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial&apos;&gt;&lt;A style=&quot;COLOR: rgb(7,130,193)&quot; href=&quot;http://www.globenewswire.com/news-release/2019/05/07/1818441/0/en/Natural-Health-Trends-Reports-First-Quarter-2019-Financial-Results.html&quot; data-cke-saved-href=&quot;http://www.globenewswire.com/news-release/2019/05/07/1818441/0/en/Natural-Health-Trends-Reports-First-Quarter-2019-Financial-Results.html&quot;&gt;First Quarter&amp;nbsp;2019 Financial Results&lt;/A&gt;&lt;/P&gt;
&lt;UL style=&apos;FONT-SIZE: 13px; FONT-FAMILY: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(51,51,51); PADDING-BOTTOM: 0px; FONT-STYLE: normal; PADDING-TOP: 0px; PADDING-LEFT: 40px; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; PADDING-RIGHT: 40px; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial&apos;&gt;
&lt;LI&gt;Total revenue of $19.3 million decreased 63% compared to $52.4 million in the first quarter of 2018 primarily due to a decline in Greater China revenue.&lt;/LI&gt;
&lt;LI&gt;Net loss was $1.9 million, or $0.17 per diluted share, compared to net income of $8.8 million, or $0.78 per diluted share, in the first quarter of 2018.&lt;EM&gt;&lt;/EM&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style=&apos;FONT-SIZE: 13px; FONT-FAMILY: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(51,51,51); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial&apos;&gt;Management Commentary&lt;/P&gt;
&lt;P style=&apos;FONT-SIZE: 13px; FONT-FAMILY: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(51,51,51); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial&apos;&gt;&amp;#8220;As we previously disclosed, in response to the Chinese government&amp;#8217;s announcement of its 100-day campaign in January, as was the case with many peer companies, we voluntarily suspended our member activities,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &amp;#8220;The suspension covered more than 90% of the number of days in the first quarter, which also included the Chinese New Year holidays. We have made it our priority to fully cooperate with the government and to proactively ensure we continue to conduct our business in compliance with all applicable laws in China. While our financial performance was adversely impacted by this initiative during the quarter, we strongly support the actions taken by the Chinese government to root out bad products and deceptive practices in order to protect Chinese consumers.&amp;#8221;&lt;/P&gt;
&lt;P style=&apos;FONT-SIZE: 13px; FONT-FAMILY: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(51,51,51); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial&apos;&gt;Mr. Sharng further commented, &amp;#8220;While the 100-day campaign expired in late April, there has been no official conclusion to end the program. We have great confidence in our ability to navigate the business through uncertain times and to renew growth once the macroclimate improves. While we are cautious as it relates to our overall performance for the remainder of 2019 given the uncertain trade and regulatory environment, we were pleased with the outcome of our successful major event in Hong Kong at the end of March and ongoing support of our market leaders. We were also thrilled to have launched NHT Global in India and remain encouraged by the continued growth we have been experiencing in Latin America, led by Peru.&amp;#8221;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=58653</link></item><item><title>Research</title><guid isPermaLink="false">58285</guid><pubDate>Fri, 22 Feb 2019 17:07:02 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trends_corp____c/overview&quot;&gt;&lt;STRONG&gt;Natural Health Trends Corp.&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt;&amp;nbsp;(NASDAQ:NHTC) ($14.11, marked down  18% pre market; $159.7M market cap),&lt;/STRONG&gt;&amp;nbsp;is a direct-selling and e-commerce company that markets premium quality personal care, wellness, and &amp;#8220;quality of life&amp;#8221; products under the NHT Global brand. NHTC&amp;nbsp;&lt;A  href=&quot;https://globenewswire.com/news-release/2019/02/21/1739824/0/en/Natural-Health-Trends-Reports-Fourth-Quarter-and-Full-Year-2018-Financial-Results.html&quot;&gt;reported&lt;/A&gt;&amp;nbsp;its Q4 2018 results, which it had pre&amp;nbsp;&lt;A  href=&quot;https://globenewswire.com/news-release/2019/01/17/1701362/0/en/Natural-Health-Trends-Announces-Fourth-Quarter-and-Full-Year-2018-Preliminary-Revenue-Estimates.html&quot;&gt;announced&lt;/A&gt;&amp;nbsp;on January 17, 2019. While both sales and EPS declined year over year and sequentially, the real takeaway from the release was that it appears to us that management may have shut down China operations in January 2019. China accounts for over 90% of the company&amp;#8217;s revenue.&lt;/P&gt;
&lt;BLOCKQUOTE&gt;
&lt;P&gt;&amp;#8220;While we experienced attractive growth in many global markets and are encouraged by the continuing positive sentiment from our leaders, given the global macroeconomic backdrop and the increased regulatory and media scrutiny in China, we are cautious regarding our performance in 2019 due to the potential impact on our operations from the global trade environment, exchange rate fluctuations, adverse local publicity and the Chinese government&amp;#8217;s 100-day campaign. As a result of this campaign and consistent with our past strategies and those of peers, we voluntarily decided in January to temporarily suspend our member activities while proactively cooperating with all relevant government agencies to ensure we continue to conduct our business in compliance with all applicable laws in China.&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;On January 7, 2019 we&amp;nbsp;&lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trends_corp____c/research/research/0067074&quot;&gt;discussed&lt;/A&gt;&amp;nbsp;that CCTV (China Central Television is the predominant state television broadcaster in China) aired an 18 minute&amp;nbsp;&lt;A  href=&quot;https://baijiahao.baidu.com/s?id=1621819555282197155&quot;&gt;program&lt;/A&gt;&amp;nbsp;that alleged NHTC was a pyramid scheme in China. Since the CCTV airing, we also highlighted the following developments:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;City of Harbin, China investigating to see if the company has any related business in its city 
&lt;LI&gt;Weak Q4 sales number, which was a result of business operations prior to negative press 
&lt;LI&gt;Most notably, the industrial and commercial department (SAIC) of Beijing has officially launched an investigation into the company&amp;#8217;s Beijing office, which was confirmed by a reporter at the 21st Century Business Herald&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;We remain short from our initial January position. It is worth noting that the company&amp;#8217;s current book value per share is about $7.9, and that its cash per share is $11.73. We believe it is a fair assumption that the company&amp;#8217;s cash position will begin to decrease from current levels as they deal with the uncertainties surrounding its China operations.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=58285</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">58281</guid><pubDate>Fri, 22 Feb 2019 14:36:44 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;https://globenewswire.com/news-release/2019/02/21/1739824/0/en/Natural-Health-Trends-Reports-Fourth-Quarter-and-Full-Year-2018-Financial-Results.html&quot; target=_blank&gt;Fourth Quarter 2018 Financial Results&lt;/A&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Total revenue of $41.6 million decreased 10% compared to $46.1 million in the fourth quarter of 2017, and decreased 12% compared to $47.0 million in the third quarter of 2018.&lt;/LI&gt;
&lt;LI&gt;Net income was $5.6 million, or $0.49 per diluted share, compared to a net loss of $4.5 million, or $0.40 per diluted share, in the fourth quarter of 2017, and net income of $7.6 million, or $0.67 per diluted share, in the third quarter of 2018.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Management Commentary&lt;/P&gt;
&lt;P&gt;&amp;#8220;While 2018 was a challenging year, I&amp;#8217;m very pleased with the ability of our company and members to navigate the difficult macroeconomic environment,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &amp;#8220;This unpredictable and challenging operating climate, driven by increased global trade tensions, China&amp;#8217;s slowing economy and a weaker currency resulted in a decline in revenue. Notably, the Chinese Yuan&amp;#8217;s depreciation of 10% against the Hong Kong dollar since February essentially made our products more expensive for our Chinese consumers in 2018. Without the impact of the Yuan devaluation, revenue for the full year of 2018 would have been flat with 2017.&amp;#8221;&lt;/P&gt;
&lt;P&gt;Mr. Sharng further commented, &amp;#8220;While we experienced attractive growth in many global markets and are encouraged by the continuing positive sentiment from our leaders, given the global macroeconomic backdrop and the increased regulatory and media scrutiny in China, we are cautious regarding our performance in 2019 due to the potential impact on our operations from the global trade environment, exchange rate fluctuations, adverse local publicity and the Chinese government&amp;#8217;s 100-day campaign. As a result of this campaign and consistent with our past strategies and those of peers, we voluntarily decided in January to temporarily suspend our member activities while proactively cooperating with all relevant government agencies to ensure we continue to conduct our business in compliance with all applicable laws in China. While I am confident this is the best approach to position our Company to successfully operate in the long-term, this suspension of member activities may have a material adverse effect on our business in the near-term. Despite these elements that are beyond our control, we remain focused on geographical expansion opportunities and leader education to further our progress.&amp;#8221;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=58281</link></item><item><title>Research</title><guid isPermaLink="false">58265</guid><pubDate>Tue, 19 Feb 2019 15:48:50 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trends_corp____c/overview&quot;&gt;&lt;STRONG&gt;Natural Health Trends Corp.&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt;&amp;nbsp;(NASDAQ:NHTC) ($15.95; $180.5M market cap),&lt;/STRONG&gt;&amp;nbsp;is a direct-selling and e-commerce company that markets premium quality personal care, wellness, and &amp;#8220;quality of life&amp;#8221; products under the NHT Global brand. An&amp;nbsp;&lt;A  href=&quot;https://www.caixinglobal.com/2019-02-15/china-suspends-registration-of-direct-selling-firms-101379899.html&quot;&gt;article&lt;/A&gt;&amp;nbsp;from Caixin Global over the weekend reported that Chinese authorities have suspended the registration and approval of direct selling licenses in the country and, more importantly, the Ministry of Commerce in China is planning to establish a &amp;#8220;blacklist&amp;#8221; of untrustworthy direct selling companies and participants:&lt;/P&gt;
&lt;BLOCKQUOTE&gt;
&lt;P&gt;&amp;#8220;The Ministry of Commerce will establish a &amp;#8220;blacklist&amp;#8221; of untrustworthy direct selling companies and participants, ministry spokesperson Gao Feng said Thursday at a routine press conference.&lt;/P&gt;
&lt;P&gt;The move came after probes and crackdowns on several large-scale health products direct selling groups following consumer complaints of exaggerated advertisements and questionable products that could even hurt people&amp;#8217;s health.&amp;#8221;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;We believe recent reports on NHTC&amp;#8217;s business practices in China could lead to it being included on this list, and we will continue to follow the story closely.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=58265</link></item><item><title>Research</title><guid isPermaLink="false">58049</guid><pubDate>Tue, 22 Jan 2019 15:43:09 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trends_corp____c/overview&quot;&gt;&lt;STRONG&gt;Natural Health Trends Corp.&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt;&amp;nbsp;(NASDAQ:NHTC) ($15.81; $178.3M market cap),&lt;/STRONG&gt;&amp;nbsp;is a direct-selling and e-commerce company that markets premium quality personal care, wellness, and &amp;#8220;quality of life&amp;#8221; products under the NHT Global brand.&lt;/P&gt;
&lt;P&gt;On January 19, 2019, NHTC China held a media conference during which it issued a public apology letter, according to numerous&amp;nbsp;&lt;A  href=&quot;https://finance.sina.com.cn/chanjing/gsnews/2019-01-21/doc-ihrfqziz9552175.shtml&quot;&gt;reports&lt;/A&gt;. In the letter, the company admitted that a number of members exaggerated Noni Juice&amp;#8217;s function/effect and also exaggerated NHTC&amp;#8217;s product distribution and consumption model, which misled consumers and caused economic loss for certain members. In addition, the company also stated in the letter that it will review and self-correct the issues mentioned by the media including product effect exaggeration, multi-level member development, mixing between product consumption and product distribution, etc.&lt;/P&gt;
&lt;P&gt;This letter seems to contradict how the company initially&amp;nbsp;&lt;A  href=&quot;https://globenewswire.com/news-release/2019/01/07/1680913/0/en/Natural-Health-Trends-Rejects-False-Allegations-and-Reiterates-Commitment-to-Ethical-Business-Practices.html&quot;&gt;responded&lt;/A&gt;&amp;nbsp;to the CCTV program regarding NHTC&amp;#8217;s suspected pyramid scheme activity in China:&lt;/P&gt;
&lt;BLOCKQUOTE&gt;
&lt;P&gt;&amp;#8220;The Company rejects the claims made that Natural Health Trends is operating illegally in China. The Company believes short sellers arranged with associates at CCTV to create a deceptive expos&amp;#233; about the Company and its products attempting to misleadingly portray the business as a pyramid scheme.&amp;#8221;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;Second, our take on the press conference is that the company appears to be shifting the blame to certain members that participated in its membership program, possibly to limit the liability to the company&amp;#8217;s overall business and activities in China. We still believe that investigations from regulatory authorities will move forward and that more bad news could be on its way.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=58049</link></item><item><title>Research</title><guid isPermaLink="false">58039</guid><pubDate>Fri, 18 Jan 2019 17:23:55 GMT</pubDate><description>&lt;P&gt;&lt;STRONG&gt;Moving long-dated puts in NHTC out of January and into later months&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Over the past two weeks we have highlighted several negative factors surrounding the NHTC story.&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;CCTV airing an expos&amp;#233; claiming the company operates a suspected illegal pyramid scheme 
&lt;LI&gt;City of Harbin, China investigating to see if the company has any related business in its city 
&lt;LI&gt;Weak Q4 sales number, which was a result of business operations prior to negative press 
&lt;LI&gt;Most notably, the industrial and commercial department (SAIC) of Beijing has officially launched an investigation into the company&amp;#8217;s Beijing office, which was confirmed by a reporter at the 21st Century Business Herald&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;We continue to believe that the chances are high that government will ultimately take action against NHTC and shut down their business. You can see our full coverage on NHTC&amp;nbsp;&lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trends_corp____c/research&quot;&gt;here.&lt;/A&gt;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=58039</link></item><item><title>Research</title><guid isPermaLink="false">58035</guid><pubDate>Thu, 17 Jan 2019 17:27:18 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trends_corp____c/overview&quot;&gt;&lt;STRONG&gt;Natural Health Trends Corp.&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt;&amp;nbsp;(NASDAQ:NHTC) ($16.11; $182.3M market cap),&lt;/STRONG&gt;&amp;nbsp;is a direct-selling and e-commerce company that markets premium quality personal care, wellness, and &amp;#8220;quality of life&amp;#8221; products under the NHT Global brand. NHTC announced preliminary Q4 2018 sales to be $41.6 million compared to $46.1 million in the prior year and also down sequentially from Q3 2018 of $47.0 million. &amp;nbsp;&lt;/P&gt;
&lt;P&gt;On January 7, 2019 we&amp;nbsp;&lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trends_corp____c/research/research/0067074&quot;&gt;discussed&lt;/A&gt;&amp;nbsp;that CCTV (China Central Television is the predominant state television broadcaster in China) aired an 18 minute&amp;nbsp;&lt;A  href=&quot;https://baijiahao.baidu.com/s?id=1621819555282197155&quot;&gt;program&lt;/A&gt;&amp;nbsp;that alleged NHTC was a pyramid scheme in China.&lt;/P&gt;
&lt;P&gt;We believe there will be a dramatic negative impact on NHTC&amp;#8217;s business in China due to this CCTV program in the immediate future. It is also possible there could be more bad news coming up (i.e. regulatory investigation, continued media coverage) for the company.&lt;/P&gt;
&lt;P&gt;An interesting takeaway from this years&amp;#8217; sales release is that the company&amp;nbsp;&lt;STRONG&gt;does not mention&lt;/STRONG&gt;&amp;nbsp;it is looking forward to a great year ahead, as it has the past two years.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=58035</link></item><item><title>Investor Alert</title><guid isPermaLink="false">58034</guid><pubDate>Thu, 17 Jan 2019 16:05:35 GMT</pubDate><description>&lt;H1&gt;Breaking: &lt;/H1&gt;
&lt;H1&gt;After the CCTV exposure, the industrial and commercial departments of Beijing and Harbin launched an investigation into the company. &lt;/H1&gt;
&lt;P&gt;21st Century Business Herald 21 Finance APP Huang Bin Beijing Report &lt;/P&gt;
&lt;P&gt;2019-01-17 &lt;/P&gt;
&lt;P&gt;On January 17, the 21st Century Business Herald learned that the Beijing Industrial and Commercial Department had launched an investigation into the company that was previously suspected of pyramid schemes by CCTV. &lt;/P&gt;
&lt;P&gt;&amp;#8220;The industry and commerce said that it is taking the time to contact the branch office, and finally will report the results in writing to tell me the results.&amp;#8221; A Beijing lawyer told the 21st Century Business Herald that he was recently commissioned by the family members of the Ran Global member. Reported to Beijing Chaoyang Industrial and Commercial Bureau and received this reply, &quot;They said that the branch is now cooperating with the investigation.&quot; The lawyer also showed the reporter a copy of the internal health information of the company. According to the statistics of the reporters, the propaganda materials listed more than 20 Chinese and foreign high-ranking members sharing their feelings. Among them, Ma Mou, Zhang Mouqiu and other members have frequently appeared in the publicity materials of the previous Health Global. &lt;/P&gt;
&lt;P&gt;&quot;There are a lot of introductions from the nine-level members. We feel that the industry and commerce may also be able to investigate from these individuals, so we will add some clues to the past,&quot; the lawyer told reporters. &lt;/P&gt;
&lt;P&gt;The reporter called the Chaoyang Industrial and Commercial Bureau and confirmed that the bureau is investigating Ran Global, but the other party said that it could not disclose the progress of the case under investigation. &lt;/P&gt;
&lt;P&gt;On the evening of January 5, CCTV released an exclusive survey, &amp;#8220;Is the juice to cure all diseases?&amp;#8221; Ran Health Global is suspected of MLM&amp;#8217;s launching. It pointed out that Ran Global has packaged its main product &amp;#8220;Noli Juice&amp;#8221; into &amp;#8220;can effectively improve various common Disorders, even terminal illnesses, even if they are regular medicines, it is difficult to compare the magical effects of its magical products. At the same time, it is better than the sales of products, and the senior members of the company are more keen to make big money together. The argument is to pull people into the conference.&quot; On the same day, CCTV also released the titled &quot;Ranjian Global is suspected of pyramid schemes: market disorder, where is regulation? &quot;The commentary program, further analysis of this matter. Previously, an in-depth article by Dr. Clove, &amp;#8220;The Health of the Ten Thousands of Health Essences, and the Chinese Family in Its Shadows&amp;#8221; unraveled the dark corners of the domestic health care products market. &lt;/P&gt;
&lt;P&gt;In this context, 13 departments including the State Administration of Markets and General Administration held a joint televised &amp;#8220;health&amp;#8221; market chaos on January 8th. Carry out a 100-day joint rectification of the &amp;#8220;health&amp;#8221; market chaos. &lt;/P&gt;
&lt;P&gt;Since then, local governments have successively introduced plans to rectify the chaos in the healthcare market. Among them, the Harbin Food and Drug Administration held a special action promotion conference on combating rectification of fraudulent sales of health products to the elderly, and mentioned that &amp;#8220;the conference has deployed the relevant work of the whole city to investigate Quanjian and Ranjian Global.&amp;#8221; &lt;/P&gt;
&lt;P&gt;The reporter called the Harbin Food and Drug Administration several times to understand the progress, but as of press time, the phone could not be connected. &lt;/P&gt;
&lt;P&gt;(Editor: Ma Chunyuan) &lt;/P&gt;
&lt;P&gt;&lt;A  href=&quot;https://m.21jingji.com/article/20190117/herald/bbd1f935e9c4253c09171f1742ea6d59.html&quot;&gt;https://m.21jingji.com/article/20190117/herald/bbd1f935e9c4253c09171f1742ea6d59.html &lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp; &lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=58034</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">58031</guid><pubDate>Thu, 17 Jan 2019 14:56:27 GMT</pubDate><description>&lt;P&gt;HONG KONG, Jan. 17, 2019 (&lt;A  href=&quot;http://www.globenewswire.com/news-release/2019/01/17/1701362/0/en/Natural-Health-Trends-Announces-Fourth-Quarter-and-Full-Year-2018-Preliminary-Revenue-Estimates.html&quot; target=_blank&gt;GLOBE NEWSWIRE&lt;/A&gt;) -- Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness, and &amp;#8220;quality of life&amp;#8221; products under the NHT Global brand, today announced its preliminary revenue estimates for the fourth quarter and full year of 2018.&lt;/P&gt;
&lt;P&gt;The Company estimates total revenue for the fourth quarter and full year ended December 31, 2018 to be $41.6 million and $191.9 million, respectively, compared to $46.1 million and $197.6 million in the comparable periods of 2017. The Company further estimates that its deferred revenue at December 31, 2018 increased $2.3 million to $6.8 million, compared to $4.5 million at September 30, 2018 due to the success of repeat order promotions near year end. At December 31, 2017, deferred revenue was $4.5 million, compared to $3.6 million at September 30, 2017.&lt;/P&gt;
&lt;P&gt;&amp;#8220;In spite of our effective sales initiatives, our preliminary revenue estimate for the fourth quarter of 2018 also reflected the current challenging market conditions of increased global trade tensions, China&amp;#8217;s slowing economy and a weaker Chinese currency. Even with these headwinds, the fourth-quarter and full-year orders were roughly flat year-over-year on a constant currency basis,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &lt;/P&gt;
&lt;P&gt;Last week the Chinese government announced a comprehensive 100-day campaign nationwide to review and focus on the regulations for certain food, equipment, daily necessities, small home electrical appliances and services that producers claim to promote health functions. While the results of this program are not yet clear, the Company believes this is a positive development that will benefit Chinese consumers and NHT Global in the long-term.&lt;/P&gt;
&lt;P&gt;The Company expects to issue its complete fourth quarter and full year 2018 financial results in mid-February.&amp;nbsp; The revenue estimates are preliminary and have not yet been reviewed by the Company&amp;#8217;s independent accountants. Significant updates and revisions may be required before the release of the Company&amp;#8217;s fourth quarter and full year 2018 financial results.&amp;nbsp; In addition, the Company&amp;#8217;s financial results will include other factors necessary to calculate additional financial metrics, including gross profit and net income.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=58031</link></item><item><title>Research</title><guid isPermaLink="false">58005</guid><pubDate>Wed, 09 Jan 2019 18:23:20 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trends_corp____c/overview&quot;&gt;&lt;STRONG&gt;Natural Health Trends Corp.&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt;&amp;nbsp;(NASDAQ:NHTC) ($15.71; $177.8M market cap),&lt;/STRONG&gt;&amp;nbsp;is a direct-selling and e-commerce company that markets premium quality personal care, wellness, and &amp;#8220;quality of life&amp;#8221; products under the NHT Global brand. &amp;nbsp;On Monday, we discussed that there was a CCTV expos&amp;#233; alleging the Company is a pyramid scheme in China. You can see our original note&lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trends_corp____c/research/research/0067074&quot;&gt;&amp;nbsp;here&lt;/A&gt;.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The controversy already caught the attention of the City of Harbin, China. &amp;nbsp;We don&apos;t think this type of action will be isolated to just the area mentioned in this&amp;nbsp;&lt;A  href=&quot;http://www.harbin.gov.cn/art/2019/1/9/art_4929_601515.html&quot;&gt;article&lt;/A&gt;. According to the article, the City of Harbin, Heilongjiang Province, is trying to find out if there are any Quanjian or NHTC related business activities in their city. We believe this is just the beginning, and other cities might follow in suit.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=58005</link></item><item><title>Research</title><guid isPermaLink="false">57997</guid><pubDate>Mon, 07 Jan 2019 17:45:18 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trends_corp____c/overview&quot;&gt;&lt;STRONG&gt;Natural Health Trends Corp.&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt;&amp;nbsp;(NASDAQ:NHTC) ($19.77; marked down  12%; $223.7M market cap),&lt;/STRONG&gt;&amp;nbsp;a direct-selling and e-commerce company that markets premium quality personal care, wellness, and &amp;#8220;quality of life&amp;#8221; products under the NHT Global brand, appears to be back in the Chinese media, as state owned CCTV aired a scathing piece that argued NHTC is running a deceptive pyramid scheme based on false product claims in China. As a reminder, we have&amp;nbsp;&lt;A  href=&quot;https://seekingalpha.com/author/the-geoteam#regular_articles&amp;amp;ticker=nhtc&quot;&gt;previously written about NHTC&lt;/A&gt;, noting in 2016 that we believed its offices in China had been raided by the SAIC and subsequently shut down. Furthermore we provided evidence to back up our belief that the company was operating an illegal pyramid scheme.&amp;nbsp;&lt;STRONG&gt;&lt;EM&gt;NHTC gets upward of 90% of its revenue from China.&lt;/EM&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;A recent CCTV expos&amp;#233; followed in the steps of a major&lt;A  href=&quot;http://money.163.com/18/1225/16/E3SS2TKN00258105.html&quot;&gt;&amp;nbsp;report&lt;/A&gt;&amp;nbsp;in China on a company called Quanjian, which wound up being labeled a pyramid scheme by the government and seeing 18 of its members, including the company&amp;#8217;s controller, being detained by authorities. Quanjian actually has a direct selling license in China,&amp;nbsp;&lt;STRONG&gt;&lt;EM&gt;NHTC does not.&lt;/EM&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;On January 5, 2019, CCTV Channel 13 (China Central Television is the predominant state television broadcaster in China) aired an 18 minute&lt;A  href=&quot;https://baijiahao.baidu.com/s?id=1621819555282197155&quot;&gt;&amp;nbsp;program&lt;/A&gt;&amp;nbsp;that alleged NHTC was a pyramid scheme in China. The program interviewed people who had experience as members of NHTC and who subsequently lost money or saw their lives reach points of turmoil, including divorce, as a result.&lt;/P&gt;
&lt;P&gt;The program also aired conversations where senior members of the company exaggerated the effects of the company&amp;#8217;s products, including one called Noni Juice. According to the program, NHTC&amp;#8217;s Noni Juice does not have domestic approval and registrations related to wellness foods.&lt;/P&gt;
&lt;P&gt;People can become members of NHTC by purchasing about RMB 18,000 worth of products, and based on an online conference held by senior members of NHTC, members&amp;#8217; income is directly linked to how many new members they recruit. The senior member in the online conference called NHTC&amp;#8217;s income model as &amp;#8220;World&amp;#8217;s 8th Miracle&amp;#8221;.&lt;/P&gt;
&lt;P&gt;The CCTV program also went through NHTC&amp;#8217;s history in China. In 2004, NHTC was reported on by another CCTV program for being a suspected pyramid scheme (its company back then was called Lexxus International Co., Ltd). One month after that, NHTC registered another company to conduct similar business. In 2007, the State Administration for Industry and Commerce announced 17 pyramid scheme organizations, including NHTC&amp;#8217;s Hong Kong branch. In the same year, NHTC changed its name again to the current name ???? (NHT Global), according to the CCTV program. NHTC&amp;#8217;s stock was decimated and went to pennies as a result of the regulatory intervention. The stock subsequently rose in ensuing years as business in China again picked up &amp;#8220;under the radar&amp;#8221;.&lt;/P&gt;
&lt;P&gt;The law expert on the CCTV program stated that NHTC&amp;#8217;s business activity in China is a pyramid scheme because its business&amp;nbsp;&lt;EM&gt;appears&amp;nbsp;&lt;/EM&gt;to be selling juice, but it actually makes money through recruiting members. The law expert further stated that if the activity is serious enough, it can be criminal.&lt;/P&gt;
&lt;P&gt;Before the NHTC expos&amp;#233; aired on CCTV, there was a major&lt;A  href=&quot;http://money.163.com/18/1225/16/E3SS2TKN00258105.html&quot;&gt;&amp;nbsp;report&lt;/A&gt;&amp;nbsp;in China on a company called Quanjian, which was accused of promoting its products of being able to cure many diseases and operating a pyramid scheme in China. Quanjian has a direct selling license (&lt;EM&gt;NHTC does not even have a direct selling license in Chin&lt;/EM&gt;a), and according to the most recent&lt;A  href=&quot;https://news.ifeng.com/c/7jGMUC9iWUC&quot;&gt;&amp;nbsp;update&lt;/A&gt;, 18 criminal suspects related to Quanjian have been detained for further investigation.&lt;/P&gt;
&lt;P&gt;Back to NHTC,&amp;nbsp;&lt;STRONG&gt;we believe this pyramid scheme investigation/reporting trend in China is directly from the central government&lt;/STRONG&gt;&amp;nbsp;and now that national TV and media are all putting their eyes on it, it is&amp;nbsp;&lt;STRONG&gt;&lt;EM&gt;highly possible&lt;/EM&gt;&lt;/STRONG&gt;&amp;nbsp;that regulators will step up to deal with suspected pyramid scheme companies, i.e. State Administration for Industry and Commerce Department, state and local police, etc.&lt;/P&gt;
&lt;P&gt;Yesterday, NHTC put out a&lt;A  href=&quot;https://globenewswire.com/news-release/2019/01/07/1680913/0/en/Natural-Health-Trends-Rejects-False-Allegations-and-Reiterates-Commitment-to-Ethical-Business-Practices.html&quot;&gt;&amp;nbsp;press release&lt;/A&gt;&amp;nbsp;regarding the program aired on CCTV on January 5, 2019. In the release, NHTC:&lt;/P&gt;
&lt;BLOCKQUOTE&gt;
&lt;P&gt;&amp;#8220;&amp;#8230;rejects the claims made that Natural Health Trends is operating illegally in China. The Company believes short sellers arranged with associates at CCTV to create a deceptive expos&amp;#233; about the Company and its products attempting to misleadingly portray the business as a pyramid scheme.&amp;#8221;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;We believe, due to the current pyramid scheme investigation/reporting trend in China, the impact of this CCTV program to NHTC&amp;#8217;s business in China could be profound, despite NHTC&amp;#8217;s denial of any illegal business conducted there. It is obvious that reporter(s) in the CCTV program already know certain senior members of NHTC in China, so it is likely regulators would question those members or trace them to even higher-level members for investigation.&lt;/P&gt;
&lt;P&gt;In addition, SAIC might go to NHTC&amp;#8217;s China offices/branches for investigation. These investigations could negatively impact NHTC&amp;#8217;s business operations in China, because people that were originally planning to become members of the company will likely hesitate and current members of NHTC might consider withdrawing their memberships based on the CCTV program. Furthermore, people that lost money as previous members of NHTC might step up and file complaints to local regulators, which would give regulators more incentive to investigate the company.&lt;/P&gt;
&lt;P&gt;Another thing that investors need to pay attention to is that according to SEC&lt;A  href=&quot;https://www.sec.gov/Archives/edgar/data/912061/000091206118000017/0000912061-18-000017-index.htm&quot;&gt;&amp;nbsp;filing&lt;/A&gt;s, one of NHTC&amp;#8217;s board directors, George K. Broady&amp;#8217;s family trusts are sizeable NHTC&amp;#8217;s shareholders, and collectively they pledged 2 million NHTC&amp;#8217;s shares to secure a line of credit. The details of the share pledge agreement remain unknown and whether the share pledge has been released or not needs to be updated on the next proxy statement.&amp;nbsp;&lt;STRONG&gt;If the share pledge is still effective, that means 64% of the total shares owned by Broady&amp;#8217;s family trusts are pledged and 17.6% of the total shares outstanding of NHTC have been pledged.&lt;/STRONG&gt;&amp;nbsp;If the stock price of NHTC drops sharply due to this CCTV program and the share pledge is still effective, it is possible that whoever received NHTC&amp;#8217;s shares as a pledge might be forced to sell the shares once certain conditions are triggered (i.e. a margin call).&lt;/P&gt;
&lt;P&gt;To sum up, we believe there will be a dramatic negative impact on NHTC&amp;#8217;s business in China due to this CCTV program in the immediate future. It is also possible there could be more bad news coming up, i.e. regulatory investigation, for the company.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=57997</link></item><item><title>Company Rebuttal</title><guid isPermaLink="false">57991</guid><pubDate>Mon, 07 Jan 2019 14:29:24 GMT</pubDate><description>&lt;P&gt;HONG KONG, Jan. 07, 2019 (&lt;A  href=&quot;http://www.globenewswire.com/news-release/2019/01/07/1680913/0/en/Natural-Health-Trends-Rejects-False-Allegations-and-Reiterates-Commitment-to-Ethical-Business-Practices.html&quot; target=_blank&gt;GLOBE NEWSWIRE&lt;/A&gt;) -- Natural Health Trends Corp. (NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and &amp;#8220;quality of life&amp;#8221; products under the NHT Global brand, issued the following statement in response to speculations and allegations falsely purported against the Company in a segment that aired on January 5, 2019 on China Central Television (&amp;#8220;CCTV&amp;#8221;). The Company rejects the claims made that Natural Health Trends is operating illegally in China. The Company believes short sellers arranged with associates at CCTV to create a deceptive expos&amp;#233; about the Company and its products attempting to misleadingly portray the business as a pyramid scheme.&lt;/P&gt;
&lt;P&gt;Natural Health Trends, a U.S. public company listed on the NASDAQ stock market, distributes its products in more than 40 countries and regions around the world. The Company complies with all applicable laws and regulations to protect the rights and interests of consumers, and benefits from a robust international compliance program.&lt;/P&gt;
&lt;P&gt;&amp;#8220;Natural Health Trends is committed to conducting business with honesty, integrity and fairness in accordance with the highest ethical standards,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &amp;#8220;We are confident that our operations in China are in compliance with all applicable regulations. We believe these inaccurate claims were made in an effort to damage our brand, business in China, reputation and shareholder value, and we are prepared to vigorously defend our Company.&amp;#8221;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=57991</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">57568</guid><pubDate>Tue, 30 Oct 2018 15:06:18 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://www.globenewswire.com/news-release/2018/10/30/1639188/0/en/Natural-Health-Trends-Reports-Third-Quarter-2018-Financial-Results.html&quot; target=_blank&gt;Third Quarter 2018 Financial Results&lt;/A&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Total revenue of $47.0 million increased 17% compared to $40.1 million in the third quarter of 2017, and decreased 8% compared to $50.9 million in the second quarter of 2018.&lt;/LI&gt;
&lt;LI&gt;Net income was $7.6 million, or $0.67 per diluted share, compared to net income of $7.3 million, or $0.65 per diluted share, in the third quarter of 2017, and $9.0 million, or $0.80 per diluted share, in the second quarter of 2018.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Management Commentary&lt;/P&gt;
&lt;P&gt;&amp;#8220;Despite a generally difficult trading environment, our performance in the third quarter was driven by the momentum we created since the beginning of the year,&amp;#8221; commented Chris Sharng, President of Natural Health Trends. &amp;#8220;So far in 2018, both a rapidly depreciating Chinese yuan, down 10% since February, and the seasonality associated with the summer months, contributed to an 8% decline in our revenue from the second quarter to the third quarter this year. Without the adverse effect of the yuan devaluation, our third quarter revenue would have been flat with the second quarter. While we have no control over these conditions, I believe we have been doing a good job navigating in an increasingly difficult and unpredictable setting.&amp;#8221;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=57568</link></item><item><title>Research</title><guid isPermaLink="false">56940</guid><pubDate>Fri, 20 Jul 2018 15:32:35 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trends_corp____c/overview&quot;&gt;&lt;STRONG&gt;Natural Health Trends Corp.&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt;&amp;nbsp;(NASDAQ:NHTC) ($20.50; $231M market cap),&lt;/STRONG&gt;&amp;nbsp;a direct-selling and e-commerce company that markets premium quality personal care, wellness, and &amp;#8220;quality of life&amp;#8221; products under the NHT Global brand, appears to be back in the Chinese media - and not for good reasons.&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;&lt;A  href=&quot;http://finance.ifeng.com/a/20180719/16394210_0.shtml&quot;&gt;iFeng report&lt;/A&gt;&amp;nbsp;was one of many in the Chinese media that noted NHTC could be under criminal investigation for illegal direct sales and smuggling. We have been following the NHTC story for years - noting in 2016 when the company&amp;#8217;s Beijing office appeared to be raided by Chinese SAIC authorities.&lt;/P&gt;
&lt;P&gt;We have been skeptical about the company&amp;#8217;s ecommerce business, which is located in Hong Kong but does most of its sales in China without a direct selling license. China and Hong Kong, according to the company&amp;#8217;s last 10-Q, account for over 93% of the company&amp;#8217;s total revenue. We put out the&amp;nbsp;&lt;A  href=&quot;https://twitter.com/GeoInvesting/status/1019977009815064576&quot;&gt;following Tweet&lt;/A&gt;&amp;nbsp;yesterday:&lt;/P&gt;
&lt;P&gt;&lt;A  href=&quot;https://twitter.com/GeoInvesting/status/1019977009815064576&quot;&gt;&lt;IMG style=&quot;BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; MARGIN: 5px 0px; WIDTH: 376px; HEIGHT: 175px; BORDER-RIGHT-WIDTH: 0px&quot; src=&quot;https://lh4.googleusercontent.com/dXFU6EZo3iJ5YqL5VjWu-jLWwEO4HzAwv6N5u7ONysVuM0rucBLKkRs1SG6SsGoMwBamiG_DEcB4oQYlu2LN4AofKG2jy6KF1RGzQRxW6l0NtOIpWL5LQfBMs1o5LnTQx1x4UmX8&quot;&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;This morning, the company&amp;nbsp;&lt;A  href=&quot;https://www.streetinsider.com/Press+Releases/Natural+Health+Trends+Issues+Response+to+Allegation/14418259.html&quot;&gt;issued a response&lt;/A&gt;&amp;nbsp;to the negative buzz around this development, stating that it is unaware of any investigation:&lt;/P&gt;
&lt;BLOCKQUOTE&gt;
&lt;P&gt;&amp;#8220;It has been brought to our attention that a Chinese website cited an anonymous source alleging that we are under investigation by a provincial police department in China. &amp;nbsp;We are unaware of such an investigation,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &amp;#8220;Should we learn of any material information regarding this allegation, we will promptly notify the investment community.&amp;#8221;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=56940</link></item><item><title>Company Rebuttal</title><guid isPermaLink="false">56938</guid><pubDate>Fri, 20 Jul 2018 13:24:19 GMT</pubDate><description>&lt;P&gt;LOS ANGELES, July 20, 2018 (&lt;A  href=&quot;http://www.globenewswire.com/news-release/2018/07/20/1540146/0/en/Natural-Health-Trends-Issues-Response-to-Allegation.html&quot; target=_blank&gt;GLOBE NEWSWIRE&lt;/A&gt;) -- Natural Health Trends Corp. (NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and &amp;#8220;quality of life&amp;#8221; products under the NHT Global brand, issued the following statement in response to an allegation made against the Company through an online posting from July 19, 2018.&lt;/P&gt;
&lt;P&gt;&amp;#8220;It has been brought to our attention that a Chinese website cited an anonymous source alleging that we are under investigation by a provincial police department in China.&amp;nbsp; We are unaware of such an investigation,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &amp;#8220;Should we learn of any material information regarding this allegation, we will promptly notify the investment community.&amp;#8221;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=56938</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">56856</guid><pubDate>Thu, 12 Jul 2018 13:26:36 GMT</pubDate><description>&lt;P&gt;LOS ANGELES, July 12, 2018 (&lt;A  href=&quot;http://www.globenewswire.com/news-release/2018/07/12/1536581/0/en/Natural-Health-Trends-Announces-Second-Quarter-2018-Preliminary-Revenue-Estimate.html&quot; target=_blank&gt;GLOBE NEWSWIRE&lt;/A&gt;) -- Natural Health Trends Corp. (NASDAQ:NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness, and &amp;#8220;quality of life&amp;#8221; products under the NHT Global brand, today announced its preliminary revenue estimate for the second quarter of 2018.&lt;/P&gt;
&lt;P&gt;The Company estimates total revenue for the second quarter ended June 30, 2018 to be $50.9 million, representing a decrease of 1% compared to $51.5 million in the second quarter of 2017 and a decrease of 3% compared to $52.4 million in the first quarter of 2018. The Company further estimates that its deferred revenue at June 30, 2018 was $3.8 million, compared to $4.1 million at March 31, 2018. At June 30, 2017, deferred revenue was $4.0 million, compared to $4.3 million at March 31, 2017.&lt;/P&gt;
&lt;P&gt;&amp;#8220;The second quarter reflected a continuation of the momentum we have been experiencing since the fourth quarter of 2017,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &amp;#8220;However, during the quarter we held most of the out-of-market activities, including incentive trips to Australia and Seattle, for which the performance-based qualifications concluded in previous periods. While our members&amp;#8217; travel, coupled with an uncertain global trade environment and currency headwinds, muted our second quarter sales growth, we were pleased to have maintained our order volume from the first quarter of 2018.&amp;#8221;&lt;/P&gt;
&lt;P&gt;The Company expects to issue its complete second quarter 2018 financial results in early August.&amp;nbsp; The revenue estimate is preliminary and has not yet been reviewed by the Company&amp;#8217;s independent accountants. Significant updates and revisions may be required before the release of the Company&amp;#8217;s second quarter 2018 financial results.&amp;nbsp; In addition, the Company&amp;#8217;s financial results will include other factors necessary to calculate additional financial metrics, including gross profit and net income.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=56856</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">56419</guid><pubDate>Wed, 02 May 2018 14:37:52 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://www.globenewswire.com/news-release/2018/05/02/1495002/0/en/Natural-Health-Trends-Reports-First-Quarter-2018-Financial-Results.html&quot; target=_blank&gt;First Quarter 2018 Financial Results&lt;/A&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Total revenue of $52.4 million decreased 13% compared to $59.9 million in the first quarter of 2017 and increased 14% compared to $46.1 million in the fourth quarter of 2017.&lt;/LI&gt;
&lt;LI&gt;Net income was $8.8 million, or $0.78 per diluted share, compared to net income of $10.4 million, or $0.93 per diluted share, in the first quarter of 2017.&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Management Commentary&lt;/P&gt;
&lt;P&gt;&amp;#8220;Our momentum in the back half of 2017 carried into 2018 with our total revenue increasing 14% over the prior quarter, marking our second consecutive quarter of sales growth,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &amp;#8220;Our improved top-line performance is a direct result of the enhancements made to our commission plan to better incentivize up-and-coming members and ease rank advancement, along with our effective marketing programs. We also held our international Ambassador Academy in Hong Kong, which attracted over 5,500 people. The orders generated by promotions directly related to the event exceeded those of the last three years.&amp;#8221;&lt;/P&gt;
&lt;P&gt;Mr. Sharng further commented, &amp;#8220;With our revenue for the quarter improved, 2018 is off to a good start. Our leaders remain energized and enthusiastic and we look forward to more productive incentive trips and targeted training programs this year to drive further progress and growth.&amp;#8221;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=56419</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">56263</guid><pubDate>Thu, 12 Apr 2018 13:20:25 GMT</pubDate><description>&lt;P&gt;LOS ANGELES, April 12, 2018 (&lt;A  href=&quot;http://www.globenewswire.com/news-release/2018/04/12/1469291/0/en/Natural-Health-Trends-Announces-First-Quarter-2018-Preliminary-Revenue-Estimate.html&quot; target=_blank&gt;GLOBE NEWSWIRE&lt;/A&gt;) -- Natural Health Trends Corp. (NASDAQ:NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness, and &amp;#8220;quality of life&amp;#8221; products under the NHT Global brand, today announced its preliminary revenue estimate for the first quarter of 2018.&lt;/P&gt;
&lt;P&gt;The Company estimates total revenue for the first quarter ended March 31, 2018 to be $52.4 million, representing a decrease of 13% compared to $59.9 million in the first quarter of 2017 and an increase of 14% compared to $46.1 million in the fourth quarter of 2017. The Company further estimates that its deferred revenue at March 31, 2018 was $4.1 million, compared to $4.5 million at December 31, 2017. At March 31, 2017, deferred revenue was $4.3 million, compared to $4.9 million at December 31, 2016.&lt;/P&gt;
&lt;P&gt;&amp;#8220;Our estimated total revenue for the first quarter of 2018 represented the second sequential quarterly increase since last September,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &amp;#8220;In addition to our international Ambassador Academy in January which attracted over 5,500 members and guests, we believe that the enhancements we made to our commission plan to better incentivize up-and-coming members, coupled with successful marketing programs, predominately drove the sequential sales growth. We look forward to various productive incentive trips and targeted training programs in 2018 to drive further progress and growth.&amp;#8221;&lt;/P&gt;
&lt;P&gt;The Company expects to issue its complete first quarter 2018 financial results in early May.&amp;nbsp; The revenue estimate is preliminary and has not yet been reviewed by the Company&amp;#8217;s independent accountants. Significant updates and revisions may be required before the release of the Company&amp;#8217;s first quarter 2018 financial results.&amp;nbsp; In addition, the Company&amp;#8217;s financial results will include other factors necessary to calculate additional financial metrics, including gross profit and net income.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=56263</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">55924</guid><pubDate>Wed, 14 Feb 2018 14:23:40 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://www.globenewswire.com/news-release/2018/02/14/1348145/0/en/Natural-Health-Trends-Reports-Fourth-Quarter-and-Full-Year-2017-Financial-Results.html&quot; target=_blank&gt;Fourth Quarter 2017 Financial Results&lt;/A&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Total revenue of $46.1 million decreased 26% compared to $62.3 million in the fourth quarter of 2016, and increased 15% compared to $40.1 million in the third quarter of 2017. &lt;/LI&gt;
&lt;LI&gt;Net loss was $4.5 million, or $0.40 per diluted share, compared to net income of $19.0 million, or $1.70 per diluted share, in the fourth quarter of 2016, and net income of $7.3 million, or $0.65 per diluted share, in the third quarter of 2017.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;#8220;While 2017 was a challenging year, we regained momentum in the fourth quarter with the first sequential quarter of sales growth since mid-2016,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &amp;#8220;The overall sales decline can be traced to factors beyond our control which hindered our members&amp;#8217; ability to organize meetings and conduct business, including the G20 Summit in late 2016, the 20th Anniversary of Hong Kong&amp;#8217;s handover and China&amp;#8217;s Communist Party&amp;#8217;s 19th National Congress.&amp;#8221;&lt;/P&gt;
&lt;P&gt;Mr. Sharng further commented, &amp;#8220;We believe our ability to increase sales over the prior quarter was a result of the improvements we made to our commission plan, combined with a number of productive incentive trips and training programs held throughout the year. Additionally, we continued to gain traction in international markets such as Europe, Southeast Asia and Japan, which all grew sales over 2016. We have also worked hard to preserve our strong margin profile despite our top-line decline through diligent expense management that aligned our cost structure to current sales levels. As we look ahead to 2018, we believe our targeted training programs and promotions, opportunities for international expansion and new product introductions will translate into improved financial performance in the quarters to come.&amp;#8221;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=55924</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">55778</guid><pubDate>Wed, 17 Jan 2018 15:08:03 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://www.globenewswire.com/news-release/2018/01/16/1289860/0/en/Natural-Health-Trends-Announces-Fourth-Quarter-and-Full-Year-2017-Preliminary-Revenue-Estimates.html&quot; target=_blank&gt;Fourth Quarter 2018 Financial Results&lt;/A&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;The Company estimates total revenue for the fourth quarter ended December 31, 2017 to be $46.1 million, representing a decrease of 26% compared to $62.3 million in the fourth quarter of 2016 and an increase of 15% compared to $40.1 million in the third quarter of 2017. For the full year ended December 31, 2017, the Company estimates total revenue to be $197.6 million, compared to $287.7 million in 2016.&lt;/LI&gt;
&lt;LI&gt;The Company further estimates that its deferred revenue at December 31, 2017 was $4.5 million, compared to $3.6 million at September 30, 2017. At December 31, 2016, deferred revenue was $4.9 million, compared to $4.2 million at September 30, 2016.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;#8220;Our revenue estimate reflects the first sequential quarter increase in net sales that we have experienced since the second quarter of 2016,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &amp;#8220;We have been working with our leaders to revitalize growth and believe the enhancements to our commission programs, coupled with incentive trips and training programs held during the quarter and throughout the year helped deliver improved sales. We look forward to a productive first-half event to kick off 2018 ahead of the Chinese New Year later this month.&amp;#8221;&lt;/P&gt;
&lt;P&gt;The Company expects to issue its complete fourth quarter and full year 2017 financial results in mid-February.  The revenue estimates are preliminary and have not yet been reviewed by the Company&amp;#8217;s independent accountants. Significant updates and revisions may be required before the release of the Company&amp;#8217;s fourth quarter and full year 2017 financial results.  In addition, the Company&amp;#8217;s financial results will include other factors necessary to calculate additional financial metrics, including gross profit and net income.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=55778</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">55181</guid><pubDate>Mon, 16 Oct 2017 13:21:15 GMT</pubDate><description>&lt;P&gt;LOS ANGELES, Oct. 13, 2017 (&lt;A  href=&quot;http://www.globenewswire.com/news-release/2017/10/13/1145794/0/en/Natural-Health-Trends-Announces-Third-Quarter-2017-Preliminary-Revenue-Estimate.html&quot; target=_blank&gt;GLOBE NEWSWIRE&lt;/A&gt;) -- Natural Health Trends Corp. (NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness, and &amp;#8220;quality of life&amp;#8221; products under the NHT Global brand, today announced its preliminary revenue estimate for the quarter ended September 30, 2017.&lt;/P&gt;
&lt;P&gt;The Company estimates total revenue for the third quarter to be $40.1 million, compared to $70.7 million in the third quarter of 2016. The Company further estimates that its deferred revenue at September 30, 2017 was $3.6 million, compared to $4.0 million at June 30, 2017. At September 30, 2016, deferred revenue was $4.2 million, compared to $8.8 million at June 30, 2016.&lt;/P&gt;
&lt;P&gt;&amp;#8220;While our preliminary revenue estimate for the third quarter of 2017 reflects a year-over-year and quarter-over-quarter decline, we remain on track to revitalize sales growth,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp.&amp;nbsp; &amp;#8220;During the quarter, a temporary slowdown related to the 20th anniversary of Hong Kong&apos;s handover and the upcoming 19th National Congress of the Communist Party of China scheduled for mid-October tempered our progress.&amp;#8221;&lt;/P&gt;
&lt;P&gt;Mr. Sharng continued, &amp;#8220;Despite the challenging environment during the quarter, a number of our markets achieved double-digit sales growth including Peru, Europe, Southeast Asia and Japan. We have provided targeted training programs and implemented enhancements to our international recognition program and matching bonus to better support our leaders, who remain enthusiastic and dedicated to their own sales growth and the overall Company&amp;#8217;s success.&amp;#8221;&lt;/P&gt;
&lt;P&gt;The Company expects to issue its complete third quarter 2017 financial results in early November.&amp;nbsp; The revenue estimate is preliminary and has not yet been reviewed by the Company&amp;#8217;s independent accountants. Significant updates and revisions may be required before the release of the Company&amp;#8217;s third quarter 2017 financial results.&amp;nbsp; In addition, the Company&amp;#8217;s financial results will include other factors necessary to calculate additional financial metrics, including gross profit and net income.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=55181</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">54654</guid><pubDate>Fri, 14 Jul 2017 13:22:49 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://www.globenewswire.com/news-release/2017/07/14/1047062/0/en/Natural-Health-Trends-Announces-Second-Quarter-2017-Preliminary-Financial-Results.html&quot; target=_blank&gt;Second Quarter 2017 Financial Results&lt;/A&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;The Company estimates total revenue for the second quarter to be $51.5 million, compared to $80.4 million in the second quarter of 2016. The Company further estimates that its deferred revenue at June 30, 2017 was $4.0 million, compared to $4.3 million at March 31, 2017. At June 30, 2016, deferred revenue was $8.8 million, compared to $6.5 million at March 31, 2016.&lt;/LI&gt;
&lt;LI&gt;Earnings per diluted share for the second quarter are estimated to be in the range of $0.85 to $0.90, compared to $1.07 per diluted share in the second quarter of 2016.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;#8220;Our preliminary revenue estimate for the second quarter of 2017 remained under pressure as our leaders continued to progress through the slowdown we have been experiencing in our Asian markets since the third quarter of 2016,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp.&amp;nbsp; &amp;#8220;In order to reinvigorate momentum in Asia, we have enhanced our incentive programs, launched new promotions and prepared for our summer event in Kuala Lumpur. Further, the second quarter of 2016 presented a difficult year-over-year comparison as a significant product price increase was phased in starting from June last year, pulling demand forward into the quarter a year ago, which led to record product orders. Partially offsetting the sales decline during the second quarter of 2017 was strength in Europe and the market opening in Peru as well as a positive response to our recent product introductions. Importantly, we have been able to successfully retain all of our top ranked leaders through these challenging times and morale remains strong.&amp;#8221;&lt;/P&gt;
&lt;P&gt;The Company expects to issue its complete second quarter 2017 financial results in early August.&amp;nbsp; The estimates for the Company&amp;#8217;s financial results are preliminary and have not yet been reviewed by the Company&amp;#8217;s independent accountants. Significant updates and revisions may be required before the release of the Company&amp;#8217;s second quarter 2017 financial results.&amp;nbsp; In addition, the Company&amp;#8217;s financial results will include other factors necessary to calculate additional financial metrics, including gross profit and net income.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=54654</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">53989</guid><pubDate>Thu, 27 Apr 2017 04:00:00 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://www.globenewswire.com/news-release/2017/04/27/973588/0/en/Natural-Health-Trends-Reports-First-Quarter-2017-Financial-Results.html&quot; target=_blank&gt;First Quarter 2017 Financial Results&lt;/A&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Total revenue decreased 19% to $59.9 million, compared to $74.3 million in the first quarter of 2016.&lt;/LI&gt;
&lt;LI&gt;Net income was $10.4 million, or $0.93 per diluted share, compared to $11.3 million, or $0.95 per diluted share, in the first quarter of 2016.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;#8220;Our first quarter 2017 revenue declined year-over-year as we are still working to overcome the slowdown we have been experiencing since the third quarter of 2016,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &amp;#8220;We also moved our first half major event from early January in prior years, to March this year, making the year-over-year comparison challenging. In addition, the stronger dollar made our products more expensive for our Chinese consumers. Partially offsetting the factors affecting our top-line was heightened productivity in March, following our successful Ambassador Academy in Macau, which attracted over 6,000 members and guests. We were very pleased with the record turnout after moving the event to after the Chinese New Year, which we believe will improve the member experience longer-term.&amp;#8221;&lt;/P&gt;
&lt;P&gt;Mr. Sharng further commented, &amp;#8220;Our strong balance sheet and working capital management afford us the ability to focus on our growth initiatives while simultaneously returning capital to our valued stockholders. I am pleased to announce our Board of Directors declared a special dividend in the amount of $0.35 per share as well as an 11% increase in our quarterly dividend to $0.10 per share, compared to the prior quarter.  While it will take time for the results of our strategic initiatives to bear fruit, we are confident in our ability to attract, motivate and retain a strong member base as well as to expand our product offering into new geographies and categories.&amp;#8221;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=53989</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">53922</guid><pubDate>Thu, 13 Apr 2017 13:16:03 GMT</pubDate><description>&lt;P&gt;LOS ANGELES, April 13, 2017 (&lt;A  href=&quot;http://www.globenewswire.com/news-release/2017/04/13/960224/0/en/Natural-Health-Trends-Announces-First-Quarter-2017-Preliminary-Revenue-Estimate.html&quot; target=_blank&gt;GLOBE NEWSWIRE&lt;/A&gt;) -- Natural Health Trends Corp. (NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness, and &amp;#8220;quality of life&amp;#8221; products under the NHT Global brand, today announced preliminary estimated revenue for the quarter ended March 31, 2017.&lt;/P&gt;
&lt;P&gt;The Company estimates total revenue for the first quarter to be $59.9 million, compared to $74.3 million in the first quarter of 2016. The Company further estimates that its deferred revenue at March 31, 2017 was $4.3 million, compared to $4.9 million at December 31, 2016. At March 31, 2016, deferred revenue was $6.5 million, compared to $4.0 million at December 31, 2015.&lt;/P&gt;
&lt;P&gt;&amp;#8220;As discussed in the prior quarter, the first quarter of 2017 presented a challenging year-over-year comparison as our re-branded Ambassador Academy, which is traditionally held in January of each year, was held in March,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &amp;#8220;In addition, we experienced a slight seasonal decline due to the Chinese New Year which was in-line with historical trends. Partially offsetting these factors was heightened activity in March following our successful Ambassador Academy in Macau which attracted over 6,000 members and guests as well as a productive three week product roadshow for Premium Noni Juice. We were thrilled to introduce various new products at the March event as well as to announce exciting incentive programs for the year.&amp;#8221;&lt;/P&gt;
&lt;P&gt;The Company expects to issue its complete first quarter 2017 financial results in late April.&amp;nbsp; The revenue estimate is preliminary and has not yet been reviewed by the Company&amp;#8217;s independent accountants. Significant updates and revisions may be required before the release of the Company&amp;#8217;s first quarter 2017 financial results.&amp;nbsp; In addition, the Company&amp;#8217;s financial results will include other factors necessary to calculate additional financial metrics, including gross profit and net income.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=53922</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">53606</guid><pubDate>Wed, 08 Feb 2017 16:04:57 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://www.globenewswire.com/news-release/2017/02/08/915150/0/en/Natural-Health-Trends-Reports-Fourth-Quarter-and-Full-Year-2016-Financial-Results.html&quot; target=_blank&gt;Fourth Quarter 2016 Financial Results&lt;/A&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Total revenue decreased 15% to $62.3 million, compared to $73.7 million in the fourth quarter of 2015. 
&lt;LI&gt;Net income was $19.0 million, or $1.70 per diluted share, compared to $13.7 million, or $1.13 per diluted share, in the fourth quarter of 2015.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;#8220;2016 was a tremendous year for Natural Health Trends and reflected solid progress on our strategic plan despite some external challenges we experienced throughout the year,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &amp;#8220;Specifically, the fourth quarter reflected a continuation of some of the challenges we discussed in the prior quarter, including a slowdown in Hangzhou, one of our top three markets, after the G20 summit was held in that city last September. Local members in the affected metropolitan area were unable to organize activities and events for weeks, which are key to their effectiveness. In addition, the Chinese yuan depreciated by 7% against the Hong Kong dollar which effectively increased the price of our products for our members residing in mainland China. We expect the first quarter will also present a difficult year-over-year comparison as we plan to launch various new products at our first-half event, the re-branded Ambassador Academy, in March versus in January last year.&amp;#8221;&lt;/P&gt;
&lt;P&gt;Mr. Sharng further commented, &amp;#8220;We increased our full year 2016 revenue by 9% over 2015. We are working to strengthen growth through increased leader training and motivation while expanding our reach by geography and products. These efforts will be supported by technological advancements to enhance overall member communication and productivity. Further, due to the flexibility we have built into many of our promotions and incentive programs, we were able to generate record operating profit for the fourth quarter of 2016. I&amp;#8217;m also very pleased we will once again be declaring a special dividend in the amount of $0.35 per share as well as increasing our regular quarterly dividend to $0.09 per share. Our ability to return capital to our stockholders is due to our robust operating cash flow driven by effective management of our working capital which has kept our balance sheet strong. We look forward to a bright future for Natural Health Trends.&amp;#8221;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=53606</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">52842</guid><pubDate>Fri, 14 Oct 2016 13:17:01 GMT</pubDate><description>&lt;P&gt;TAIPEI, Taiwan--(&lt;A  href=&quot;http://www.businesswire.com/news/home/20161014005167/en/ASE-Receives-ISO-26262-Certification-Standard-Related&quot; target=_blank&gt;BUSINESS WIRE)--&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Advanced Semiconductor Engineering, Inc (ASE, TAIEX:2311, NYSE:ASX), the leading provider of semiconductor assembly and test services, today announced that its Chung Li, Taiwan facility has received the ISO 26262 certification from T&amp;#220;V NORD, a technical service provider that helps companies to validate the safety of products and services. ISO 26262 is a standard related to the safety of electrical and electronic systems within a car and addresses possible hazards caused by malfunctioning behavior of safety-related systems, including interaction of these systems.1&lt;/P&gt;
&lt;P&gt;&amp;#8216;The increasing number of electronic functions in an automotive vehicle has added to the complexity in automotive manufacturing. Such complexity also adds to the increased need for the IC assembly manufacturing process to adhere to strict automotive benchmarks and practices in order to achieve zero ppm in automotive testing. Zero ppm creates a mindset that strives to guarantee quality and reliability to ensure that vehicles are safe and dependable,&amp;#8217; says TS Chen, President of ASE Chung Li. &amp;#8216;ASE has invested time, financial and human resources to train its engineers to identify and manage risks within the manufacturing process and to avoid these risks by providing appropriate requirements and processes as outlined in the ISO 26262 standards,&amp;#8217; he continued.&lt;/P&gt;
&lt;P&gt;The ASE Chung Li site has been in the forefront of automotive IC assembly and testing, providing many of the industry&amp;#8217;s top tier automotive device players with packaging solutions for almost two decades. The facility is also TS 16949 certified and continues to improve its quality and safety standards by undertaking global certification programs. The ISO 26262 certification will greatly benefit customers and ASE as both parties would be able to shorten the time needed to verify the functional safety of all products and enable customers to reach their intended markets quickly.&lt;/P&gt;
&lt;P&gt;Heterogeneous integrated package solutions such as ASE&amp;#8217;s System-in-Package, MEMS and sensor module solutions are robust technologies developed for the myriad and sophisticated electronics that make automotive vehicles smarter and safer. In an industry that innovates non-stop, ASE is poised to grow its IC packaging portfolio and technology capability as well as the adoption of international safety and quality standards for the future in connected and autonomous cars.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=52842</link></item><item><title>Research</title><guid isPermaLink="false">52855</guid><pubDate>Fri, 14 Oct 2016 04:00:00 GMT</pubDate><description>&lt;P&gt;&lt;STRONG&gt;NHTC ($27.18, marked down to $23.90)&lt;/STRONG&gt; marked down premarket  $23.30 on its &lt;A  href=&quot;https://globenewswire.com/news-release/2016/10/13/879404/0/en/Natural-Health-Trends-Announces-Third-Quarter-2016-Reporting-Date-and-Preliminary-Revenue-Estimate.html&quot; target=_blank&gt;announced&lt;/A&gt; preliminary Q3 revenue number.&amp;nbsp; The company estimates its total revenue for Q3 2016 will be a decrease of 12% to $70.7 million, as compared to $80.8 million in Q3 2015. In addition, the company reported $80.4 million in Q2 2016.&lt;/P&gt;
&lt;P&gt;Recall, we have &lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trend/articles&quot; target=_blank&gt;written several articles&lt;/A&gt; on NHTC in 2016 purposed to discern whether or not the company is under regulatory scrutiny in China. The company&amp;#8217;s press release has stated that the lapse in revenue was due to preparations &amp;#8220;for the G20 Summit in Hangzhou, one of [the company&amp;#8217;s] top markets, such as temporarily relocating city residents, emptying entire districts, blocking urban traffic and shutting down businesses in July, August and early September&amp;#8221;.&lt;/P&gt;
&lt;P&gt;We will continue to keep a close eye on the company&amp;#8217;s business operations moving forward.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=52855</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">52328</guid><pubDate>Wed, 27 Jul 2016 13:22:29 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://www.globenewswire.com/news-release/2016/07/27/859316/0/en/Natural-Health-Trends-Reports-Strong-Second-Quarter-2016-Financial-Results.html&quot; target=_blank&gt;Second Quarter 2016 Financial Results&lt;/A&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Total revenue increased 15% to $80.4 million, compared to $69.7 million in the second quarter of 2015.&lt;/LI&gt;
&lt;LI&gt;Net income was $12.2 million, or $1.07 per diluted share, compared to $12.3 million, or $0.98 per diluted share, in the second quarter of 2015. Net income, excluding the impact of the additional tax provision, would have increased 19% to $14.6 million, or $1.29 per diluted share.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;#8220;We had an excellent second quarter characterized by record product orders and operating profit,&amp;#8221; commented Chris Sharng, President of Natural Health Trends Corp. &amp;#8220;We once again achieved a double-digit, year-over-year increase in revenue growth driven by our emphasis on products, training, services and marketing.&amp;#8221;&lt;/P&gt;
&lt;P&gt;Mr. Sharng further commented, &amp;#8220;Going forward, we will remain focused on expanding our global footprint, continuing to acquire members in new and existing markets, as well as our product development initiatives to drive sustainable, long-term growth. Through our strong cash generation, we are very well positioned to grow our business organically while simultaneously returning value to our stockholders through quarterly cash dividends and execution on our $70 million stock repurchase program.&amp;#8221;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=52328</link></item><item><title>Research</title><guid isPermaLink="false">51438</guid><pubDate>Wed, 27 Apr 2016 15:48:20 GMT</pubDate><description>&lt;P&gt;&lt;STRONG&gt;NHTC ($35.57)&lt;/STRONG&gt; &lt;A  href=&quot;http://globenewswire.com/news-release/2016/04/27/833490/0/en/Natural-Health-Trends-Reports-Strong-First-Quarter-2016-Financial-Results.html&quot;&gt;reported&lt;/A&gt; Q1 2016 results:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;P&gt;Sales of $74.3 million vs $40.7 million in the prior year&lt;/P&gt;
&lt;LI&gt;
&lt;P&gt;EPS of $0.95 vs $0.54 in the prior year&lt;/P&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;On April 12, 2016 when NHTC announced the preliminary revenue results for this quarter, we&lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trend/research/research/0058937&quot;&gt;stated&lt;/A&gt;:&lt;/P&gt;
&lt;BLOCKQUOTE&gt;
&lt;P&gt;&amp;#8220;while Q1 2016 was slightly up from its Q4 2015 revenue of $73.6 million, it is still $6.5 million lower than the reported Q3 2015 revenue. It seems as though business may have peaked in Q3 2015 - a reason we believe NHTC may desperately need to obtain a direct selling license in China in order to further grow its business base.&amp;#8221;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;NHTC will now start facing tough quarterly comparables going forward. &amp;nbsp;Without obtaining a direct selling license or offering more clarity on the outlook with the conversations with government officials regarding its business practices, &amp;nbsp;it may be challenging for the Company to attract distributors which would impact future revenue growth. &amp;nbsp;&amp;nbsp;The Company is going up against $0.98, $1.18 and $1.12 respectively for the next 3 quarters of EPS comps.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=51438</link></item><item><title>Research</title><guid isPermaLink="false">51347</guid><pubDate>Tue, 12 Apr 2016 17:08:40 GMT</pubDate><description>&lt;P&gt;&lt;STRONG&gt;NHTC ($34.85)&lt;/STRONG&gt; announced &lt;A  href=&quot;http://finance.yahoo.com/news/natural-health-trends-report-first-130000910.html&quot;&gt;preliminary Q1 2016 revenues&lt;/A&gt; of $74.3 million vs $40.7 million in the prior year period. The company&amp;#8217;s press release stated:&lt;/P&gt;
&lt;BLOCKQUOTE&gt;
&lt;P&gt;&amp;#8220;The Company estimates total revenue for the quarter ended March 31, 2016 to be $74.3 million, which represents an increase of 83% compared to $40.7 million in the first quarter of 2015. The Company also estimates that its deferred revenue at March 31, 2016 was $6.5 million, compared to $4.0 million at December 31, 2015. At March 31, 2015, deferred revenue was $10.4 million, compared to $2.7 million at December 31, 2014.&amp;#8221;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;The reported preliminary revenue for Q1 2016 was slightly up from its Q4 2015 revenue of $73.6 million, however, it is still $6.5 million lower than the reported Q3 2015 revenue. It seems as though business may have peaked in Q3 2013 - a reason we believe NHTC may desperately need to obtain a direct selling license in China in order to further grow its business base.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=51347</link></item><item><title>Research</title><guid isPermaLink="false">51138</guid><pubDate>Wed, 23 Mar 2016 15:41:21 GMT</pubDate><description>&lt;P&gt;&lt;STRONG&gt;NHTC ($36.05)&lt;/STRONG&gt; On March 23rd, 2016, we found a construction notice on the door of NHTC&amp;#8217;s Beijing office. &amp;nbsp;The notice appears to state that Beijing Shengjia Kaiao Construction Engineering Corp. Limited is going to be remodeling NHTC&amp;#8217;s Beijing office. &amp;nbsp;&lt;/P&gt;
&lt;P&gt;We didn&amp;#8217;t see any official seal from either NHTC and/or the construction company on the notice. We cannot confirm the content and facts of this notice. We remain cautious of this notice and we will continue to conduct more due diligence regarding this issue on a daily basis.&lt;/P&gt;
&lt;P&gt;There are a lot of moving parts to the NHTC story and being short the equity has been costly. We believe the short in NHTC is crowded and that there&amp;#8217;s little retail in the stock. Combining this with the company&amp;#8217;s newly authorized buyback makes NHTC a volatile name to be in. If we have the opportunity, we will trade both long and short around our core short position in the near term.&lt;/P&gt;
&lt;P&gt;Despite this, Directors continue to sell stock.&lt;/P&gt;
&lt;P&gt;Over the course of the long term, we continue to believe NHTC will have a poor performance this year that will stop their momentum and we continue to believe, based on our on the ground due diligence, that the Chinese government is still investigating the company.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=51138</link></item><item><title>Research</title><guid isPermaLink="false">51123</guid><pubDate>Mon, 21 Mar 2016 17:45:13 GMT</pubDate><description>&lt;P&gt;&lt;STRONG&gt;NHTC Director Sells Another 20,000 Shares&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;On Friday &amp;nbsp;we stated NHTC &amp;nbsp;Director George Broady sold 30,000 shares on 3/16 and 3/17, the two days after we issued our&lt;A  href=&quot;http://seekingalpha.com/article/3958573-natural-health-trends-beijing-office-shut&quot;&gt;report&lt;/A&gt; noting that the company&amp;#8217;s Beijing office appears to have been shut down. He sold 30,000 shares for a total of about $900,000. &amp;nbsp;A Form 4&lt;A  href=&quot;https://www.sec.gov/Archives/edgar/data/912061/000091206116000021/xslF345X03/wf-form4_145833901193309.xml&quot;&gt;&lt;/A&gt;filed after hours Friday shows Broady sold another 20,000 shares at $30.17 on 3/18/2016.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=51123</link></item><item><title>Research</title><guid isPermaLink="false">51119</guid><pubDate>Fri, 18 Mar 2016 17:40:50 GMT</pubDate><description>&lt;P&gt;&lt;STRONG&gt;NHTC Director Sells $900K in Stock in the Two Days Following Our Report&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;According to &lt;A  href=&quot;https://www.sec.gov/Archives/edgar/data/912061/000091206116000020/xslF345X03/wf-form4_145824879134097.xml&quot;&gt;this Form 4&lt;/A&gt;, NHTC Director George Broady sold 30,000 shares on 3/16 and 3/17, the two days after we issued our &lt;A  href=&quot;http://seekingalpha.com/article/3958573-natural-health-trends-beijing-office-shut&quot;&gt;report&lt;/A&gt; noting that the company&amp;#8217;s Beijing office appears to have been shut down. He sold 30,000 shares for a total of about $900,000. The company never bothered to issue a response to our articles and update U.S. investors regarding the status of their Beijing office.&lt;/P&gt;
&lt;P&gt;Yesterday, on one of the company&amp;#8217;s Chinese websites, a &lt;A  href=&quot;http://www.nhtglobal.com.cn/newsview.aspx?id=145&amp;amp;from=singlemessage&amp;amp;isappinstalled=0&quot;&gt;small note&lt;/A&gt; appeared that again said the company is undergoing a remodel at its Beijing facility.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=51119</link></item><item><title>Research</title><guid isPermaLink="false">50737</guid><pubDate>Thu, 14 Jan 2016 16:15:49 GMT</pubDate><description>&lt;P&gt;&lt;STRONG&gt;As NHTC Responds to Media Reports, We Continue Our Due Diligence&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Yesterday we released our article called &amp;#8220;&lt;A  href=&quot;http://geoinvesting.com/video-obtained-by-geoinvesting-confirms-another-police-raid-on-natural-health-trends-nhtc-headquarter/&quot;&gt;Another Day, Another Raid&lt;/A&gt;&amp;#8221; which detailed a police presence at NHTC&amp;#8217;s Guangzhou headquarters just days after SINA Finance and other reputable media outlets in China reported that the company&apos;s satellite offices in Beijing were &amp;#8220;raided&amp;#8221;. After hearing this news, we sent our investigator to Guangzhou, where they were able to collect &lt;A  href=&quot;http://geoinvesting.com/video-obtained-by-geoinvesting-confirms-another-police-raid-on-natural-health-trends-nhtc-headquarter/&quot;&gt;&amp;nbsp;video and photographs&lt;/A&gt; of uniformed police and SAIC officials with NHTC employees shortly after arriving on the scene at NHTC&amp;#8217;s headquarters in Guangzhou. The company responded yesterday in a &lt;A  href=&quot;http://finance.yahoo.com/news/natural-health-trends-refutes-false-180824993.html&quot;&gt;press release&lt;/A&gt;, claiming among other things:&lt;/P&gt;
&lt;P style=&quot;MARGIN-LEFT: 40px&quot;&gt;&amp;#8220;The Company believes that some Chinese accusers, working in tandem with parties making online posts, have been aggressively pressing the Beijing City government to conduct an investigation of Natural Health Trends. The Company&amp;#8217;s staff attorney and branch manager participated in a meeting with the Beijing Chaoyang District SAIC and the Public Security Bureau at Natural Health Trends&amp;#8217; Beijing office on January 11, 2016. Two accusers were present, though they declined to exchange business cards with the Company&amp;#8217;s employees. The outcome of this meeting, which has been grossly mischaracterized in an online posting as a government &amp;#8220;raid,&amp;#8221; was that the government authorities advised the Company and the accusers that there was insufficient evidence to warrant an investigation of Natural Health Trends. &amp;nbsp;No office computers or other Company property has been removed from Natural Health Trends&amp;#8217; offices by Chinese governmental authorities. In a separate event, on January 13, 2016, several public security officials of various districts in the Guangzhou city visited the Company&amp;#8217;s Guangzhou office as part of a routine examination. &amp;nbsp;This is the office that is currently applying for a direct selling license.&amp;#8221;&lt;/P&gt;
&lt;P&gt;Geo made note yesterday on Twitter that the word &amp;#8220;raid&amp;#8221; was used in some of the original Chinese media posts that documented this story and that we have had no involvement with whistleblowers or contacting the Chinese government. We also note that the company&apos;s explanation of a coincidental &amp;#8220;routine examination&amp;#8221; in their main office does not pass muster with us. Uniformed police and SAIC officials would not, in our opinion, conduct a routine (joint) examination at all much less two days after NHTC&amp;#8217;s Beijing office was reportedly raided. We believe we&amp;#8217;ve seen this before, where Chinese management teams misrepresent themselves to U.S. investors, and the company&amp;#8217;s buyback comes as no surprise to us. You can read the company&amp;#8217;s full press release &lt;A  href=&quot;http://finance.yahoo.com/news/natural-health-trends-refutes-false-180824993.html&quot;&gt;here&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;We are continuing our due diligence on NHTC and we remain short.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=50737</link></item><item><title>Investor Alert</title><guid isPermaLink="false">50734</guid><pubDate>Wed, 13 Jan 2016 15:51:52 GMT</pubDate><description>&lt;SPAN lang=EN&gt;
&lt;P dir=ltr align=center&gt;&lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;
&lt;H2&gt;Another Day, Another Raid; This Time at NHTC&amp;#8217;s Guangzhou Corporate China Headquarters&lt;/H2&gt;&lt;/SPAN&gt;
&lt;P&gt;&lt;/SPAN&gt;We have uncovered brand new blockbuster evidence that shows us that the NHTC Chinese regulatory investigation is now happening on a national level, and not just at the company&amp;#8217;s satellite Beijing offices. We think this may confirm the end of NHTC&amp;#8217;s business in China. &lt;/P&gt;
&lt;P&gt;Over the last few days, we have been monitoring the &lt;A  href=&quot;http://geoinvesting.com/natural-health-trends-nhtc-breaking-news/&quot;&gt;situation &lt;/A&gt;at Natural Health Trends Corporation, where it was first alleged &lt;A  href=&quot;http://geoinvesting.com/natural-health-trends-nhtc-breaking-news/&quot;&gt;last week &lt;/A&gt;that there was a formal SAIC investigation into the company&apos;s operations in China. The company&apos;s operations in China and Hong Kong account for over 95% of the company&amp;#8217;s total sales. &lt;BR&gt;&lt;BR&gt;After our initial report, the company issued a press release claiming they were &amp;#8220;unaware&amp;#8221; of any investigation. This came the same morning as it was reported in major Chinese media, like SINA Finance, that the company was under formal investigation and that NHTC&amp;#8217;s Beijing office had been &amp;#8220;raided&amp;#8221;. &lt;/P&gt;
&lt;P&gt;In our continued due diligence, we sent one of our investigators to the company&amp;#8217;s China headquarters, which is located in Guangzhou. Shortly after &amp;nbsp;our investigator arrived, Chinese SAIC and police were both on the premises at the company&amp;#8217;s offices. &lt;BR&gt;&lt;BR&gt;This additional evidence shows that not only was the company&amp;#8217;s &lt;EM&gt;satellite office &lt;/EM&gt;in Beijing raided but that Chinese officials and Chinese police raided the company&amp;#8217;s &lt;STRONG&gt;Chinese headquarters &lt;/STRONG&gt;. We sent our investigators there, who were able to capture the follow photographs and video evidence. &lt;/P&gt;
&lt;P&gt;Here are our photographs, showing uniformed officials at NHTC&amp;#8217;s Guangzhou Corporate Headquarters: &lt;/P&gt;
&lt;P&gt;&lt;IMG style=&quot;WIDTH: 400px; HEIGHT: 393px&quot; alt=&quot;&quot; src=&quot;http://geoinvesting.com/wp-content/uploads/2016/01/nhtc-Screenshot_2.png&quot;&gt; &lt;/P&gt;
&lt;P&gt;&lt;IMG style=&quot;WIDTH: 400px; HEIGHT: 368px&quot; alt=&quot;&quot; src=&quot;http://geoinvesting.com/wp-content/uploads/2016/01/nhtc-Screenshot_1.png&quot;&gt; &lt;/P&gt;
&lt;P&gt;&lt;IMG style=&quot;WIDTH: 400px; HEIGHT: 371px&quot; alt=&quot;&quot; src=&quot;http://geoinvesting.com/wp-content/uploads/2016/01/nhtc-Screenshot_3.png&quot;&gt; &lt;/P&gt;
&lt;P&gt;And here is video footage we were able to take of uniformed officials at the same Guangzhou Corporate Headquarters: &lt;/P&gt;
&lt;P&gt;&lt;IFRAME height=500 src=&quot;https://player.vimeo.com/video/151647025&quot; frameBorder=0 width=500 allowfullscreen=&quot;&quot; mozallowfullscreen=&quot;&quot; webkitallowfullscreen=&quot;&quot;&gt;
  &lt;/IFRAME&gt;&lt;/P&gt;
&lt;P&gt;---------------- &lt;/P&gt;
&lt;P&gt;&lt;IFRAME height=500 src=&quot;https://player.vimeo.com/video/151647022&quot; frameBorder=0 width=500 allowfullscreen=&quot;&quot; mozallowfullscreen=&quot;&quot; webkitallowfullscreen=&quot;&quot;&gt;
  &lt;/IFRAME&gt;&lt;/P&gt;
&lt;P&gt;------------ &lt;/P&gt;
&lt;P&gt;&lt;IFRAME height=500 src=&quot;https://player.vimeo.com/video/151647023&quot; frameBorder=0 width=500 allowfullscreen=&quot;&quot; mozallowfullscreen=&quot;&quot; webkitallowfullscreen=&quot;&quot;&gt;
  &lt;/IFRAME&gt;&lt;/P&gt;
&lt;P&gt;After 3PM local time on 1/13/16, several police officers and SAIC officers raided the company&amp;#8217;s Guangzhou offices. Based on our observations, the officers were at the headquarters for more than two hours, appeared to search the offices and took files from the offices. The officers left the office at around 5PM, based on our observation. &lt;/P&gt;
&lt;P&gt;With this new evidence in hand, we think it is likely that the NHTC investigation by Chinese regulators is now happening on a national scale, and we continue to warn investors that 95% of all of the company&amp;#8217;s sales comes from China and Hong Kong.&amp;nbsp; &lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=50734</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">50828</guid><pubDate>Wed, 13 Jan 2016 05:00:00 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://www.sec.gov/Archives/edgar/data/912061/000091206116000014/nhtc20150113_8k.htm&quot; target=_new&gt;Item 8.01 Other Events.&lt;BR&gt;&lt;/A&gt;&amp;nbsp;&lt;BR&gt;On January 13, 2016, Natural Health Trends Corp. (the &amp;#8220;Company&amp;#8221;) issued a press release announcing it strongly refutes false allegations made against it by U.S. and Chinese parties that appear to be working in concert with the goals of improperly influencing the market for the Company&apos;s stock and damaging the Company&apos;s reputation, brand value and business in China.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;In addition, the Company&apos;s Board of Directors has authorized an increase in its previously announced stock repurchase program from $15 million to $70 million, $10 million of which has already been completed. The Company will seek to expeditiously pursue the repurchase program, consistent with applicable U.S. securities laws and prudent management of the Company&apos;s resources. The press release is attached hereto as exhibit 99.1.&lt;BR&gt;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=50828</link></item><item><title>Research</title><guid isPermaLink="false">50719</guid><pubDate>Mon, 11 Jan 2016 17:17:00 GMT</pubDate><description>&lt;P&gt;&lt;STRONG&gt;NHTC ($23.35)&lt;/STRONG&gt; &lt;A  href=&quot;http://globenewswire.com/news-release/2016/01/11/800877/0/en/Natural-Health-Trends-Announces-Fourth-Quarter-2015-Estimated-Revenue.html&quot;&gt;announced&lt;/A&gt; fourth quarter 2015 estimated revenues of $73.6 million, compared to $35.4 million in the prior year quarter. &amp;nbsp;The company also discussed the ongoing rumors of a government investigation:&lt;/P&gt;
&lt;BLOCKQUOTE&gt;
&lt;P&gt;&amp;#8220;On January 7, we became aware of an online posting alleging a government investigation of our business in China. &amp;nbsp;By January 11, our Chinese employees were in direct contact with the Beijing City&apos;s government officials. As of now, we are unaware of an investigation. We have initiated the process set forth in China&amp;#8217;s pertinent law to contact the website where the allegation was posted. &amp;nbsp;We will appropriately disclose any material, verified information.&amp;#8221;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;On Friday, we issued this &lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trend/research/research/0057977&quot;&gt;research note&lt;/A&gt; discussing the rumors that broke in China that NHTC has been investigated by the SAIC. &amp;nbsp;We continue to perform research. Please see our analysis &lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trend/research/research/0057973&quot;&gt;here.&lt;/A&gt;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=50719</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">50710</guid><pubDate>Mon, 11 Jan 2016 13:35:53 GMT</pubDate><description>&lt;P align=left&gt;BEIJING, Jan. 08, 2016 &lt;A  href=&quot;http://globenewswire.com/news-release/2016/01/11/800877/0/en/Natural-Health-Trends-Announces-Fourth-Quarter-2015-Estimated-Revenue.html&quot; target=_blank&gt;(GLOBE NEWSWIRE&lt;/A&gt;) -- BeiGene, Ltd., a clinical-stage biopharmaceutical company focused on developing molecularly-targeted and immuno-oncological drugs for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Investigational New Drug (IND) application for the clinical development of BGB-A317, a humanized monoclonal antibody against the immune checkpoint receptor PD-1 and Phase IA/IB studies for BGB-A317 may now proceed in the U.S.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;#65533;This is a significant milestone for BeiGene, and also for the wider Chinese biopharmaceutical industry,&amp;#65533; said John V. Oyler, Chief Executive Officer of BeiGene. &amp;#65533;We are honored to be at the forefront of the expanding global efforts of Chinese drug discovery.&amp;#65533;&lt;/P&gt;
&lt;P&gt;Wendy Yan, Senior Vice President and Head of Regulatory Affairs additionally commented, &amp;#65533;We are delighted to build on the success of our previous U.S. IND, for our small molecule BTK inhibitor BGB-3111, with this IND effective of our first biologic in the United States.&amp;#65533;&lt;/P&gt;
&lt;P&gt;BeiGene plans to develop BGB-A317 as a monotherapy and as a combination agent with small molecule therapeutics for various solid-organ and blood-borne cancers. The IND will allow BeiGene to include sites in the United States in its ongoing global study for BGB-A317 in patients with relapsed or refractory solid tumors. The trial, which is currently underway in Australia, is an open label, dose-escalation and expansion study to investigate the safety, pharmacokinetics, and antitumor activities of BGB-A317 in patients with advanced tumors. A total of 51 patients had been dosed in the study as of November 30, 2015.&lt;/P&gt;
&lt;P&gt;Ruirong Yuan, M.D., Chief Medical Officer and President of BeiGene Global Clinical Research and Development, commented &amp;#65533;We believe BGB-A317 is potentially differentiated from currently approved PD-1 antibodies in that its ability to bind the Fc gamma receptor I has been specifically engineered out, and we believe this could potentially lead to improved activities. In addition, BGB-A317 has unique binding characteristics to PD-1, and may have superior target specificity.&amp;#65533;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=50710</link></item><item><title>Research</title><guid isPermaLink="false">50709</guid><pubDate>Fri, 08 Jan 2016 18:41:15 GMT</pubDate><description>&lt;P&gt;&lt;STRONG&gt;Natural Health Trends China Investigation Could be Devastating: Our Analysis&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;NHTC ($25.92) is an MLM company based in the U.S. that obtains most of its revenue from China. This is a peculiarity due to the company&amp;#8217;s lack of a direct selling license in China, a country with some of the strictest MLM rules on the planet. The company has been using an e-commerce model to swing product into China from Hong Kong - a method they claim is legal, that now seems to be under investigation by Chinese authorities. In the balance hangs almost all of the company&amp;#8217;s revenue.&lt;/P&gt;
&lt;P&gt;We have been watching and following NHTC closely to try and determine whether or not the company would be able to obtain a coveted Direct Selling license in China. So far, the company has been unable to do so after almost 10 years of trying to obtain one. We have been both long and short the company over the course of the last few years, but our most recent analysis of the company led us to be extremely cautious about the way it was conducting its business. You can read our late 2014 analysis of the company in &lt;A  href=&quot;http://seekingalpha.com/article/2496345-natural-health-trends-has-all-of-its-eggs-in-one-highly-unstable-basket&quot;&gt;this article&lt;/A&gt; called &amp;#8220;Natural Health Trends Has all of its Eggs in One Highly Unstable Basket&amp;#8221;. Since then, there have also been several critical analyses on the company posted to Seeking Alpha, which you can view &lt;A  href=&quot;http://seekingalpha.com/symbol/NHTC/focus&quot;&gt;here&lt;/A&gt;. Author Duane Bair has asked the most critical questions, and we recommended taking a look at his analysis, as his work on MLMs has been accurate and prolific.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;We believe the crux of our short thesis &amp;nbsp;- that the company is skirting Chinese direct selling rules but using an e-commerce model through Hong Kong - &amp;nbsp;seems to have been validated by news yesterday of a Chinese government investigation.&lt;/STRONG&gt; On the heels of this investigation, we believe the company has the potential for total collapse.&lt;/P&gt;
&lt;P&gt;News broke Thursday morning on &lt;A  href=&quot;http://seekingalpha.com/instablog/6460311-unemon1/4691976-nhtc-game-over-news-media-report-company-being-investigated-by-chinese-authorities-see-you-at-2-usd&quot;&gt;this blog&lt;/A&gt; that Natural Health Trends Corporation has officially had an SAIC investigation opened. To read this news item and our full analysis with translation of the Chinese news article, click &lt;A  href=&quot;http://portal.geoinvesting.com/companies/nhtc_natural_health_trend/research/research/0057973&quot;&gt;here&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;We&amp;#8217;re continuing our due diligence and will update members as soon as we have updates.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=50709</link></item><item><title>Research</title><guid isPermaLink="false">50706</guid><pubDate>Thu, 07 Jan 2016 16:31:16 GMT</pubDate><description>&lt;P&gt;We have been watching and following NHTC closely to try and determine whether or not the company would be able to obtain a coveted Direct Selling license in China. So far, the company has been unable to do so after almost 10 years of trying to obtain one. We have been both long and short the company over the course of the last few years, but our most recent analysis of the company led us to be extremely cautious about the way it was conducting its business.&lt;/P&gt;
&lt;P&gt;We&amp;#8217;ve been trying to understand the business model more, but we believe the crux of our short thesis &amp;nbsp;- that the company is skirting Chinese direct selling rules but using an e-commerce model through Hong Kong - &amp;nbsp;seems to have been validated by news today of a Chinese government investigation. On the heels of this investigation, we believe the company has the potential for total collapse.&lt;/P&gt;
&lt;P&gt;News broke Thursday morning on &lt;A  href=&quot;http://seekingalpha.com/instablog/6460311-unemon1/4691976-nhtc-game-over-news-media-report-company-being-investigated-by-chinese-authorities-see-you-at-2-usd&quot;&gt;this blog&lt;/A&gt; that Natural Health Trends Corporation has officially had an SAIC investigation opened. &lt;A  href=&quot;http://toutiao.com/i6236993284414112258&quot;&gt;This link&lt;/A&gt; has the following text, which we have translated below:&lt;/P&gt;
&lt;BLOCKQUOTE&gt;
&lt;P&gt;&amp;#25509;&amp;#36817;&amp;#21271;&amp;#20140;&amp;#24066;&amp;#24037;&amp;#21830;&amp;#23616;&amp;#30340;&amp;#30693;&amp;#24773;&amp;#20154;&amp;#22763;&amp;#21521;&amp;#35760;&amp;#32773;&amp;#34920;&amp;#31034;&amp;#65292;&amp;#24037;&amp;#21830;&amp;#37096;&amp;#38376;&amp;#24050;&amp;#25484;&amp;#25569;&amp;#21271;&amp;#20140;&amp;#22320;&amp;#21306;&amp;#33509;&amp;#24178;&amp;#39592;&amp;#24178;&amp;#20250;&amp;#21592;&amp;#22312;&amp;#28982;&amp;#20581;&amp;#29615;&amp;#29699;&amp;#39321;&amp;#28207;&amp;#32593;&amp;#31449;&amp;#37324;&amp;#30340;&amp;#36134;&amp;#25143;&amp;#20449;&amp;#24687;&amp;#65292;&amp;#21253;&amp;#25324;&amp;#28041;&amp;#26696;&amp;#30340;&amp;#19978;&amp;#21315;&amp;#20250;&amp;#21592;&amp;#12289;&amp;#28040;&amp;#36153;&amp;#21152;&amp;#30431;&amp;#21830;&amp;#21517;&amp;#21333;&amp;#20197;&amp;#21450;&amp;#36825;&amp;#20123;&amp;#39592;&amp;#24178;&amp;#20250;&amp;#21592;&amp;#32047;&amp;#35745;&amp;#33719;&amp;#21033;&amp;#24773;&amp;#20917;&amp;#65292;&quot;&amp;#30001;&amp;#20110;&amp;#28041;&amp;#26696;&amp;#37329;&amp;#39069;&amp;#24040;&amp;#22823;&amp;#65292;&amp;#24037;&amp;#21830;&amp;#23616;&amp;#23545;&amp;#27492;&amp;#20107;&amp;#38750;&amp;#24120;&amp;#37325;&amp;#35270;&amp;#65292;&amp;#20174;&amp;#30446;&amp;#21069;&amp;#24050;&amp;#25484;&amp;#25569;&amp;#30456;&amp;#20851;&amp;#26448;&amp;#26009;&amp;#26469;&amp;#30475;&amp;#65292;&amp;#35813;&amp;#32452;&amp;#32455;&amp;#28041;&amp;#23244;&amp;#20256;&amp;#38144;&amp;#65292;&amp;#24050;&amp;#25253;&amp;#36865;&amp;#20844;&amp;#23433;&amp;#37096;&amp;#38376;&amp;#12290;&quot;&lt;STRONG&gt;&amp;#20030;&amp;#25253;&amp;#20154;&amp;#25552;&amp;#20379;&amp;#30340;&amp;#21271;&amp;#20140;&amp;#24066;&amp;#24037;&amp;#21830;&amp;#23616;&amp;#26576;&amp;#20998;&amp;#23616;&lt;/STRONG&gt;&lt;STRONG&gt;2015&lt;/STRONG&gt;&lt;STRONG&gt;&amp;#24180;&lt;/STRONG&gt;&lt;STRONG&gt;12&lt;/STRONG&gt;&lt;STRONG&gt;&amp;#26376;&lt;/STRONG&gt;&lt;STRONG&gt;24&lt;/STRONG&gt;&lt;STRONG&gt;&amp;#26085;&lt;/STRONG&gt;&lt;STRONG&gt;&amp;#20030;&amp;#25253;&amp;#22788;&amp;#29702;&amp;#31572;&amp;#22797;&amp;#20989;&amp;#26174;&amp;#31034;&amp;#65292;&amp;#30446;&amp;#21069;&amp;#35813;&amp;#26696;&amp;#24050;&amp;#36827;&amp;#20837;&amp;#31435;&amp;#26696;&amp;#35843;&amp;#26597;&amp;#31243;&lt;/STRONG&gt;&lt;STRONG&gt;&amp;#24207;&lt;/STRONG&gt;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;The translation is [paraphrased]:&lt;/P&gt;
&lt;BLOCKQUOTE&gt;
&lt;P&gt;A person close to Beijing SAIC told a reporter that the department has already obtained several major members&amp;#8217; (members are in Beijing district) account information on NHTC&amp;#8217;s Hong Kong website, which includes list of up to 1,000 members and consumer franchisees and these major members&amp;#8217; accumulated profits. &lt;STRONG&gt;&amp;#8220;Because the case is related to a large amount of money, the department is taking this very seriously. Based on materials obtained right now, this organization is suspected to be as a multiple-level-marketing (MLM) and reported to the Public Securities Bureau. [police]&amp;#8221;&lt;/STRONG&gt; Based on the reply notice provided by the whistleblower from the sub-division of Beijing SAIC on December 24, 2015, right now this case has already entered into investigation process. &amp;nbsp;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;To the best of our understanding the Public Securities Department is capable of taking enforcement action and the case appears to have been reported to the Public Securities Department. The key, and what we&amp;#8217;re watching for, is if it made public that the Public Securities Department has opened a formal investigation. We would believe this to be an even further ominous sign than today&amp;#8217;s investigation.&lt;/P&gt;
&lt;P&gt;We believe that after this news makes its way to the market, it could potentially have an major negative impact on NHTC and that owning the stock is far too risky at this point.&lt;/P&gt;
&lt;P&gt;This comes at the worst possible time for the company, as it has continually been seeking a direct selling license, which is necessary to conduct MLM business in China. If the company is found to have been conducting business in China illegally, the impact could be devastating.&lt;/P&gt;
&lt;P&gt;This is a significantly material event if true, because over 90% of the company&apos;s revenue comes from China and the company is using a questionable business model that we have highlighted in our &lt;A  href=&quot;http://seekingalpha.com/article/2496345-natural-health-trends-has-all-of-its-eggs-in-one-highly-unstable-basket&quot;&gt;last article&lt;/A&gt; about NHTC from September 2014. If not shut down altogether, the negative price could materially impact the amount of customers the company is able to recruit.&lt;/P&gt;
&lt;P&gt;Again, we have followed the NHTC story for the better part of the last few years. We think that the investigation is extremely significant because the last time the company was investigated in China in 2004 the business collapsed&amp;nbsp;and the stock fell to $0.09 after reach a high of over $9 when it first went public. We are taking an extremely cautious stance in dealing with NHTC. We do not believe the second time around with the Chinese government is likely to show leniency.&lt;/P&gt;
&lt;P&gt;We believe the news will filter to more mainstream sources when and if the company has to make a disclosure relating to this investigation, and when today&amp;#8217;s news is further disseminated.&lt;/P&gt;
&lt;P&gt;We had asked questions on one of the company&amp;#8217;s recent conference calls and we had investigated methods of operation and delivery within China and Hong Kong. Our findings have us concluding that the stock at this point has the potential to go much lower, as the company is a house of cards that relies &amp;nbsp;only on China.&lt;/P&gt;
&lt;P&gt;We&amp;#8217;re going to continue looking into this story to validate sources and provide updates when they become available.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=50706</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">49910</guid><pubDate>Thu, 29 Oct 2015 04:00:00 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://www.sec.gov/Archives/edgar/data/912061/000162828015007983/nhtc20151028_8k.htm&quot; target=_new&gt;Item 1.01&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Entry Into a Material Definitive Agreement.&lt;BR&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Further to the stock repurchase program announced by Natural Health Trends Corp. (the &amp;#8220;Company&amp;#8221;) on July 28, 2015, on October 28, 2015 the Company entered into a Stock Repurchase Agreement with George K. Broady (&amp;#8220;Broady&amp;#8221;), the Company&amp;#8217;s largest stockholder and a member of its board of directors (the &amp;#8220;Stock Repurchase Agreement&amp;#8221;). The Stock Repurchase Agreement, which the Company and Broady entered into in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, provides for the Company&amp;#8217;s purchase from Broady of 0.4066 of the number of shares of common stock purchased by the Company&amp;#8217;s broker in the open market under the Company&amp;#8217;s previously announced stock repurchase program.&lt;BR&gt;&amp;nbsp;&lt;BR&gt;As a part of such stock repurchase program, the Company has recently entered into a Rule 10b5-1 Issuer Repurchase Plan with its broker (the &amp;#8220;Purchase Plan&amp;#8221;) under which the Company&amp;#8217;s broker is authorized to purchase shares of the Company&amp;#8217;s common stock in the open market for a total purchase price of $3,555,000 in accordance with Rule 10b-18 under the Securities Exchange Act of 1934. The Stock Repurchase Agreement with Broady requires that the Company report to Broady on a weekly basis information regarding the broker&amp;#8217;s open market purchases, and that the Company purchase from Broady 0.4066 of the number of shares purchased by the Company&amp;#8217;s broker in the open market, which shares shall be purchased on a weekly basis from Broady at a per share purchase price equal to the weighted average price per share paid by the Company&amp;#8217;s broker to purchase shares in the open market.&lt;BR&gt;&amp;nbsp;&lt;BR&gt;The Company expects to expend approximately $5.0 million in the aggregate under the Stock Repurchase Agreement with Broady and the Purchase Plan, which when combined with the Company&apos;s prior expenditures under the stock repurchase program announced on July 28, 2015, would result in aggregate expenditures of approximately $10.0 million, plus transaction costs.&amp;nbsp; Although the Company has reserved the right to discontinue at any time the stock repurchase program, it expects that upon completion of the purchase of shares under the stock repurchase program it will have expended approximately $15.0 million, plus transactions costs.&lt;BR&gt;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=49910</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">49840</guid><pubDate>Wed, 28 Oct 2015 05:04:41 GMT</pubDate><description>&lt;A  href=&quot;http://www.globenewswire.com/news-release/2015/10/27/780543/10154098/en/Natural-Health-Trends-Reports-Strong-Third-Quarter-2015-Financial-Results.html&quot; target=_blank&gt;Third Quarter 2015 Financial Results&lt;/A&gt; 
&lt;P&gt;Total revenue increased 154% to $80.8 million, compared to $31.8 million in the third quarter of 2014.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Net income available to common stockholders was $14.5 million, or $1.18 per diluted share, compared to $5.4 million, or $0.42 per diluted share, in the third quarter of 2014.&lt;/P&gt;
&lt;P id=yui_3_18_1_1_1446007916199_2511&gt;&quot;The third quarter was a record quarter, driven by our successful execution efforts for launching and marketing our products, as well as through supporting our leaders in developing effective sales techniques,&quot; commented Chris Sharng, President of Natural Health Trends Corp. &quot;Our record third quarter revenue and net income both posted significant sequential increases and more than doubled versus the third quarter last year. Strengthened consumer demand for our products in China, coupled with strong growth in our active member base helped contribute to this impressive growth.&quot;&lt;/P&gt;
&lt;P id=yui_3_18_1_1_1446007916199_2518&gt;Mr. Sharng continued, &quot;We were very pleased to report that we have initiated the process for submitting a direct-selling license application in the Chinese province of Guangdong. We are hopeful that a license will enable us to drive incremental growth by leveraging our growing brand recognition in China as well as our Hong Kong distribution infrastructure. As we are still very early in this process, timing for obtaining our direct-selling license remains uncertain. In the interim, we will remain highly focused on managing all aspects of our core business that are within our control.&quot;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=49840</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">48881</guid><pubDate>Tue, 04 Aug 2015 08:03:37 GMT</pubDate><description>&lt;A  href=&quot;http://www.globenewswire.com/news-release/2015/07/28/755787/10143394/en/NHTC-Announces-104-Revenue-Increase-101-Net-Income-Increase-for-Second-Quarter-of-2015.html&quot; target=_blank&gt;Second Quarter 2015 Financial Results&lt;/A&gt;
&lt;UL&gt;
&lt;LI&gt;Total revenues increased 104% to $69.7 million, compared to $34.2 million in the second quarter last year.&lt;/LI&gt;
&lt;LI&gt;Net income was $12.3 million, or $0.98 per diluted share, compared to $6.1 million, or $0.49 per diluted share, in the second quarter last year.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&quot;We delivered another quarter of solid top-line growth and doubled our net income as we continue to leverage the strength and utility of our Hong Kong infrastructure to meet the increasing consumer demand for our health and wellness products,&quot; commented Chris Sharng, President of Natural Health Trends Corp. &quot;During the quarter we launched several new products to extend our product line and kicked off additional incentive programs for top performers. The combination of consumer demand supported by our market-leading products and effective sales, leadership and incentive programs are proving to be very successful strategies for expanding our base of consumers and distributors while fortifying an already firm foundation for future growth.&quot;&lt;/P&gt;
&lt;P id=yui_3_18_1_1_1438675242974_2550&gt;&quot;Our Hong Kong business continues to excel, and to date, the economic slowdown in China has not impacted us,&quot; continued Mr. Sharng. &quot;In the long term, we feel that the re-orientation of the Chinese economy toward consumption is good for businesses like ours, as we work to introduce high-quality consumer products to the increasingly affluent Chinese consumers. We are in the Chinese market for the long haul and are bullish on its prospect.&quot;&lt;/P&gt;
&lt;P id=yui_3_18_1_1_1438675242974_2548&gt;&quot;Further, during the quarter, we funded the required deposit for the consumer protection fund in China, which is a prerequisite to submitting our direct selling license application,&quot; concluded Mr. Sharng. &quot;We view applying for a direct selling license as strategically valuable to help us drive incremental growth as our brand recognition continues to grow in China and Asia.&quot;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=48881</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">48852</guid><pubDate>Fri, 31 Jul 2015 04:00:00 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://www.sec.gov/Archives/edgar/data/912061/000143774915014450/nhtc20150731_8k.htm&quot; target=_new&gt;Item 1.01&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Entry Into a Material Definitive Agreement.&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;Further to the stock repurchase program announced by Natural Health Trends Corp. (the &amp;#8220;Company&amp;#8221;) on July 28, 2015, on July 31, 2015 the Company entered into a Stock Repurchase Agreement with George K. Broady (&amp;#8220;Broady&amp;#8221;), the Company&amp;#8217;s largest stockholder and a member of its board of directors (the &amp;#8220;Stock Repurchase Agreement&amp;#8221;). The Stock Repurchase Agreement, which the Company and Broady entered into in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, provides for the Company&amp;#8217;s purchase from Broady of 0.4085 of the number of shares of common stock purchased by the Company&amp;#8217;s broker in the open market under the Company&amp;#8217;s previously announced stock repurchase program. &lt;/P&gt;
&lt;P&gt;As a part of such stock repurchase program, the Company has entered into a Rule 10b5-1 Issuer Repurchase Plan with its broker (the &amp;#8220;Purchase Plan&amp;#8221;) under which the Company&amp;#8217;s broker is authorized to purchase shares of the Company&amp;#8217;s common stock in the open market for a total purchase price of $3,550,000 in accordance with Rule 10b-18 under the Securities Exchange Act of 1934. The Stock Repurchase Agreement with Broady requires that the Company report to Broady on a weekly basis information regarding the broker&amp;#8217;s open market purchases, and that the Company purchase from Broady 0.4085 of the number of shares purchased by the Company&amp;#8217;s broker in the open market, which shares shall be purchased on a weekly basis from Broady at a per share purchase price equal to the weighted average price per share paid by the Company&amp;#8217;s broker to purchase shares in the open market. &lt;/P&gt;
&lt;P&gt;The Company expects to expend approximately $5.0 million in the aggregate under the Stock Repurchase Agreement with Broady and the Purchase Plan. Although the Company has reserved the right to discontinue at any time the stock repurchase program it announced on July 28, 2105, it expects that upon completion of the purchase of shares under the stock repurchase program it will have expended approximately $15.0 million, plus transactions costs.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=48852</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">47249</guid><pubDate>Mon, 13 Apr 2015 04:00:00 GMT</pubDate><description>&lt;P id=yui_3_16_0_1_1428930360710_1573&gt;DALLAS, April 13, 2015 (&lt;A  href=&quot;http://www.globenewswire.com/news-release/2015/03/03/712070/10122729/en/NHTC-Reports-137-Increase-in-2014-Revenues-to-124-6-Million-EPS-Increased-347-to-1-61.html&quot; target=_blank&gt;GLOBE NEWSWIRE&lt;/A&gt;) -- Natural Health Trends Corp. (NHTC) estimates revenue for the quarter ended March 31, 2015 to be $40.9 million. The Company also estimates that its deferred revenue at March 31, 2015 was $10.2 million, compared to $2.7 million at December 31, 2014. In the first quarter of 2014, revenue was $23.2 million, with deferred revenue of $7.9 million at March 31, 2014 and $2.6 million at December 31, 2013. &lt;/P&gt;
&lt;P id=yui_3_16_0_1_1428930360710_1783&gt;Increase in quarter end deferred revenue compared to a year ago was attributable to the rapid increase in total orders, the Chinese New Year falling on a later date this year compared to last year and the labor strife on the U.S. West Coast.&lt;/P&gt;
&lt;P id=yui_3_16_0_1_1428930360710_1768&gt;The revenue estimate is preliminary and has not been reviewed by the Company&apos;s independent accountants. Significant updates and revisions may be required before the release of the Company&apos;s first quarter financial results in May. In addition, the Company&apos;s quarterly financial results will include other factors necessary to calculate additional financial metrics, including gross profit and net income.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=47249</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">46629</guid><pubDate>Wed, 04 Mar 2015 05:00:00 GMT</pubDate><description>&lt;P id=yui_3_16_0_1_1425479489653_1443&gt;&lt;STRONG id=yui_3_16_0_1_1425479489653_1445&gt;&lt;A  href=&quot;http://www.globenewswire.com/news-release/2015/03/03/712070/10122729/en/NHTC-Reports-137-Increase-in-2014-Revenues-to-124-6-Million-EPS-Increased-347-to-1-61.html&quot; target=_blank&gt;Fourth Quarter Financial Results&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL id=yui_3_16_0_1_1425479489653_1414&gt;
&lt;LI id=yui_3_16_0_1_1425479489653_1413&gt;Total revenues increased 85% to $35.4 million, compared to $19.1 million in the fourth quarter last year. 
&lt;LI id=yui_3_16_0_1_1425479489653_1428&gt;Net income was $5.8 million, or $0.45 per diluted share, compared to $1.6 million, or $0.14 per diluted share, in the fourth quarter last year. &lt;/LI&gt;&lt;/UL&gt;
&lt;P id=yui_3_16_0_1_1425479489653_1285&gt;&quot;We capped off 2014 with another strong quarter, and delivered triple-digit sales growth, solid margin expansion and a more than four-fold increase in earnings per share for the year,&quot; commented Chris Sharng, President of Natural Health Trends Corp. &quot;Clearly, our marketing strategy has been effective in driving strong top- and bottom-line growth. We have been keen to develop and extend our product line while providing the necessary infrastructure, including leadership development, training and competitive incentives, to attract and retain talented distributors and leverage existing operations to increase our margins.&quot;&lt;/P&gt;
&lt;P id=yui_3_16_0_1_1425479489653_1416&gt;&quot;We recently concluded a successful event in Macau where 3,000 attended our Success Forum designed to recognize superior performance and serve as a platform for new product introductions. Our leaders are motivated and optimistic,&quot; continued Mr. Sharng. &quot;Our momentum is strong going into the new year.&quot;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=46629</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">45860</guid><pubDate>Thu, 04 Dec 2014 05:00:00 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://www.sec.gov/Archives/edgar/data/912061/000143774914021664/nhtc20141202_8k.htm&quot; target=_new&gt;Item 5.03&amp;nbsp; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;On December 3, 2014 the Company filed with the Secretary of State of the State of Delaware a Certificate of Elimination of the Series A Convertible Preferred Stock of the Company (the &amp;#8220;Certificate&amp;#8221;). The Certificate, which was effective upon filing, cancels the Company&amp;#8217;s &amp;#8220;Series A Convertible Preferred Stock,&amp;#8221; no shares of which remain outstanding as a result of the automatic conversion of all of such shares into the Company&amp;#8217;s common stock due to the fact that the average closing price of the Company&amp;#8217;s common stock equaled or exceeded $10.00 per share over a recent, consecutive trailing 6-month period.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=45860</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">45432</guid><pubDate>Tue, 04 Nov 2014 05:00:00 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://www.globenewswire.com/news-release/2014/11/05/679988/10106071/en/NHTC-Reports-Quarterly-Revenue-Increased-125-to-31-8-Million-EPS-Increased-250-to-0-42.html&quot; target=_new&gt;2014 Third Quarter Financial Results:&lt;/A&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Total revenues were $31.8 million, up 125% compared to $14.2 million in the third quarter last year. 
&lt;LI&gt;Non-GAAP of $0.42, compared to $0.12 in the third quarter last year.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&quot;We continued our strong momentum into the third quarter, with our highest level of orders in any quarter this year,&quot; commented Chris Sharng, President of Natural Health Trends Corp. &quot;We are effectively leveraging our business model, with a 308% increase in net income during the quarter. In just nine months, we have delivered a 256% increase in net income compared to all of 2013.&quot;&lt;/P&gt;
&lt;P&gt;&quot;Our efforts to add new products have helped accelerate our growth, and we are simultaneously working to improve the performance of our distributors, through leadership development and training programs, services and promotions, and this effort is showing positive results as our member base is increasingly well informed and motivated, driving higher average sales per member,&quot; continued Mr. Sharng. &quot;We remain very pleased with the recent performance and we are increasingly optimistic about the long-term future of Natural Health Trends.&quot;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;Dividend and Share Repurchase&lt;/P&gt;
&lt;P&gt;Yesterday, the Board of Directors declared a cash dividend of $0.032 per share on outstanding Series A preferred stock, which represents the accrued unpaid dividends through the declaration date, and a cash dividend of $0.01 per share on each share of common stock outstanding, representing an aggregate dividend amount of $130,000, payable in cash on December 3, 2014 to stockholders of record on November 25, 2014.&lt;/P&gt;
&lt;P&gt;Additionally, on November 4, 2014, the Board of Directors approved a special stock repurchase program of up to $5 million of the Company&apos;s outstanding shares of common stock. Such repurchases are expected to begin during November and be complete by January 2015. Such purchases will be made in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Securities Exchange Act of 1934 (the &quot;Exchange Act&quot;). For all or a portion of the authorized repurchase amount, the Company may enter into a plan that is compliant with Rule 10b5-1 of the Exchange Act that is designed to facilitate these purchases. The repurchase program does not require the Company to acquire a specific number of shares, and may be suspended from time to time or discontinued. The share repurchases will be funded from available working capital.&lt;/P&gt;
&lt;P&gt;The Company is advised by George K. Broady, its largest shareholder and a member of its Board of Directors, that Mr. Broady desires to participate in the Company&apos;s repurchase program on a basis roughly proportional to his ownership interest, with an estimate of generating approximately $1.5 million through the sale of a portion of the shares of the Company&apos;s common stock held by him. To that end, the Company and Mr. Broady are in discussions regarding the terms of a mutually agreeable stock purchase agreement.&lt;/P&gt;
&lt;P&gt;&quot;The Board of Directors believes that, at the current valuation, a stock repurchase program will serve the best interests of all shareholders and represents a compelling use of the Company&apos;s capital,&quot; added Mr. Sharng.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;Listing of Shares on The Nasdaq Capital Market&lt;/P&gt;
&lt;P&gt;Finally, on November 4, 2014, the Board of Directors authorized management to pursue the listing of its shares of common stock on The Nasdaq Capital Market. &quot;With the Company&apos;s solid and expanding profitability and strong balance sheet, the Board believes now is the optimal time to pursue a listing of our common stock,&quot; said Mr. Sharng. Although the Company believes that it will be able to satisfy Nasdaq&apos;s applicable listing requirements, there can be no assurance as to whether, or in what timeframe, it will be able to do so.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=45432</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">45177</guid><pubDate>Wed, 15 Oct 2014 04:00:00 GMT</pubDate><description>&lt;P&gt;DALLAS, Oct. 14, 2014 (&lt;A  href=&quot;http://globenewswire.com/news-release/2014/10/14/673139/10102564/en/Natural-Health-Trends-Announces-Third-Quarter-Revenue-Estimate.html&quot; target=_blank&gt;GLOBE NEWSWIRE&lt;/A&gt;) -- Natural Health Trends Corp. (OTCQB:NHTC) estimates revenue for the quarter ended September 30, 2014 to be $31.8 million. The Company also estimates that its deferred revenue at September 30, 2014 was $2.9 million, compared to $3.2 million at June 30, 2014. In the third quarter of 2013, revenue was $14.2 million, with deferred revenue of $1.5 million at September 30, 2013 and $1.1 million at June 30, 2013.&lt;/P&gt;
&lt;P&gt;The revenue estimate is preliminary and has not been reviewed by the Company&apos;s independent accountants. Significant updates and revisions may be required before the release of the Company&apos;s third quarter results. In addition, the Company&apos;s quarterly financial results will include other factors necessary to calculate additional financial metrics, including gross profit and net income.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=45177</link></item><item><title>Investor Alert</title><guid isPermaLink="false">44918</guid><pubDate>Mon, 15 Sep 2014 04:00:00 GMT</pubDate><description>&lt;P&gt;The GeoTeam recently discovered an article on315online.com.cn, a Chinese website that discusses the types and characteristics of e-commerce multi-level marketing (&amp;#8220;MLM&amp;#8221;) campaigns. The August 28, 2013 article points to the prevalence of scams associated with MLM and goes into detail about what to be cautious of, since the ubiquity of fraud is apparent in so many facets of the World Wide Web.&lt;/P&gt;
&lt;P&gt;Please see &lt;A  href=&quot;http://portal.geoinvesting.com/geoarticles/1138/natural_health_trends_has_all_of_its_eggs_in_one_highly_unstable_basket&quot;&gt;our full article here&lt;/A&gt;.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=44918</link></item><item><title>Investor Alert</title><guid isPermaLink="false">44917</guid><pubDate>Wed, 10 Sep 2014 04:00:00 GMT</pubDate><description>&lt;P&gt;Anyone following Herbalife Ltd. (HLF), Nu Skin Enterprises Inc. (NUS) and USANA Health Sciences Inc. (USNA) , know that the debate over the practices of multi-level marketing (&amp;#8220;MLM&amp;#8221;), particularly with U.S. companies operating in China, has been a hot topic. That is why investors will want to know what we have found out about Natural Health Trends Corp. (NHTC).&lt;/P&gt;
&lt;P&gt;After being long NHTC for nearly one year, we are now short NHTC.&amp;nbsp; Our preliminary due diligence is not positive.&amp;nbsp; We are still progressing with our diligence, but because NHTC fell 35% in the September 8, 2014 trading session, we thought it would prudent to alert investors to our belief that a greater implosion in shares of NHTC is in the works.&lt;/P&gt;
&lt;P&gt;Please &lt;A  href=&quot;http://www.geoinvesting.com/preliminary-due-diligence-is-not-positive/&quot;&gt;see our commentary here&lt;/A&gt;.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=44917</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">44294</guid><pubDate>Wed, 30 Jul 2014 04:00:00 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://www.globenewswire.com/news-release/2014/07/30/654449/10091284/en/NHTC-Reports-Quarterly-Revenue-More-Than-Tripled-to-34-2-Million-0-49-in-Diluted-EPS-Dividend-Increased.html&quot; target=_new&gt;&lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;Second Quarter 2014 Financial Results:&lt;/SPAN&gt;&lt;/A&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Total revenues were &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$34.2 million, up 223% compared to $10.6 million &lt;/SPAN&gt;in the second quarter last year. 
&lt;LI&gt;Diluted EPS in this quarter was &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$0.49&lt;/SPAN&gt;, compared to &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$0.08 in prior year&lt;/SPAN&gt;.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&quot;This was another excellent quarter for Natural Health Trends,&quot; remarked Chris Sharng, President of Natural Health Trends Corp. &quot;Orders taken during the second quarter were very strong. In addition, the quarter&apos;s financial results also benefited from delivering significant orders taken but unshipped in March, with shipments made during the second quarter.&quot;&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&quot;For the first six months of 2014, the Company generated more revenue and net income than it did for the entire 2013 year,&quot; added Mr. Sharng. &quot;The strong results so far in 2014 clearly demonstrate that our efforts to enhance our leadership development and training programs, and expand our products, services and promotions, can effectively drive strong results. The result has been a more informed base of members, and this has translated to higher average sales per member. We have focused particularly on investments in China, Hong Kong and Taiwan, where we think we have the most promising opportunities. Our programs aim for long-term growth. We are very pleased with the recent performance but are more excited about what we can accomplish in the long run.&quot;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=44294</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">44251</guid><pubDate>Tue, 15 Jul 2014 04:00:00 GMT</pubDate><description>&lt;P&gt;DALLAS, July 15, 2014 &lt;A  href=&quot;http://globenewswire.com/news-release/2014/07/15/650919/10089422/en/Natural-Health-Trends-Announces-Second-Quarter-Revenue-Estimate.html&quot; target=_blank&gt;(GLOBE NEWSWIRE&lt;/A&gt;) -- Natural Health Trends Corp. (OTCQB:NHTC) estimates revenue for the quarter ended June 30, 2014 to be $34.2 million. The Company also estimates that its deferred revenue at June 30, 2014 was $3.2 million, compared to $7.9 million at March 31, 2014. In the second quarter of 2013, revenue was $10.6 million, with deferred revenue of $1.1 million at each of June 30, 2013 and March 31, 2013.&lt;/P&gt;
&lt;P&gt;The revenue estimate is preliminary and has not been reviewed by the Company&apos;s independent accountants. Significant updates and revisions may be required before the release of the Company&apos;s second quarter results. In addition, the Company&apos;s quarterly financial results will include other factors necessary to calculate additional financial metrics, including gross profit and net income.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=44251</link></item><item><title>Deal Flow</title><guid isPermaLink="false">43940</guid><pubDate>Tue, 17 Jun 2014 04:00:00 GMT</pubDate><description>&lt;P style=&quot;TEXT-ALIGN: center&quot;&gt;&lt;A  href=&quot;http://www.sec.gov/Archives/edgar/data/912061/000143774914011343/nhtc20140612_424b3.htm&quot; target=_new&gt;&lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;NATURAL HEALTH TRENDS CORP.&lt;/SPAN&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: center&quot;&gt;&lt;BR&gt;930,794 shares of common stock issuable upon exercise of warrants &lt;/P&gt;
&lt;P&gt;This prospectus relates to the sale or other disposition of up to a total of 930,794 shares of our common stock, par value $0.001, that may be offered from time to time by the selling stockholders listed on page 16 of this prospectus or their transferees. The shares being offered by this prospectus are issuable upon the exercise of warrants held by the selling stockholders. The warrants were issued in a private placement financing completed in October 2007. &lt;/P&gt;
&lt;P&gt;This prospectus also covers any additional shares of common stock that may become issuable upon any anti-dilution adjustment pursuant to the terms of the above-described warrants by reason of stock splits, stock dividends, or similar events. &lt;/P&gt;
&lt;P&gt;We will receive no proceeds from the sale or other disposition of shares of our common stock by the selling stockholders. However, we will receive proceeds of $3.5137 per share from the exercise of any of the warrants, except to the extent that any such warrants are exercised on a cashless basis. &lt;/P&gt;
&lt;P&gt;The selling stockholders may sell or otherwise dispose of the shares of common stock covered by this prospectus in a number of different ways and at varying prices. For a description of the plan of distribution of the shares, please see page 18 of this prospectus. The selling stockholders will pay all brokerage fees and commissions and similar expenses. We will pay all expenses (except brokerage fees and commissions and similar expenses) relating to the registration of the shares with the Securities and Exchange Commission (the &amp;#8220;SEC&amp;#8221; or &amp;#8220;Commission&amp;#8221;).&lt;/P&gt;
&lt;P&gt;Our common stock is quoted under the symbol &amp;#8220;NHTC&amp;#8221; on the OTCQB tier of the OTC Market. The last sales price of our common stock on June 13, 2014 was $6.43 per share. &lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=43940</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">43458</guid><pubDate>Wed, 07 May 2014 04:00:00 GMT</pubDate><description>&lt;P&gt;&lt;STRONG&gt;&lt;A  href=&quot;http://globenewswire.com/news-release/2014/05/07/633982/10080401/en/Natural-Health-Trends-Reports-Continued-Momentum-Record-First-Quarter-Financial-Results.html&quot; target=_new&gt;First Quarter 2014 Financial Results&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Total revenues were &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$23.2 million, up 168% compared to $8.7 million&lt;/SPAN&gt;&lt;SPAN&gt;&amp;nbsp;in &lt;/SPAN&gt;the first quarter last year and up &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;21% sequentially &lt;/SPAN&gt;compared to $&lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;19.1 million&lt;/SPAN&gt; for the fourth quarter last year. 
&lt;LI&gt;Net income was &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$3.1 million, or $0.26 per diluted share&lt;/SPAN&gt;, compared to &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$283,000, or $0.0&lt;/SPAN&gt;3 &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;per diluted share&lt;/SPAN&gt;, last year and &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$1.6 million, or $0.14 per diluted share&lt;/SPAN&gt;, for the fourth quarter last year.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&quot;The strong momentum we built in 2013 continued into the first quarter,&quot; commented Chris Sharng, President of Natural Health Trends Corp. &quot;Net sales in Hong Kong increased 237% and sales in Taiwan increased 12% compared to the first quarter of last year, demonstrating the strong organization we have built in these two important geographies. We continue to expand our gross profitability, grow our operating income and expand our free cash flow, helping to support our prospect for long-term growth.&quot;&lt;/P&gt;
&lt;P&gt;&quot;Our focus is on sustaining this momentum and continuing to drive improved results,&quot; added Mr. Sharng. &quot;All of the critical business drivers that we built: leader support, promotional plans, training, product development, member services and commissions plan are working effectively. We expect 2014 will be an exceptional year for Natural Health Trends, its members, customers and shareholders.&quot;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=43458</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">43190</guid><pubDate>Mon, 14 Apr 2014 04:00:00 GMT</pubDate><description>&lt;SPAN itemprop=&quot;articleBody&quot;&gt;
&lt;P&gt;DALLAS, April 14, 2014 (&lt;A  href=&quot;http://globenewswire.com/news-release/2014/04/14/626929/10076481/en/Natural-Health-Trends-Announces-First-Quarter-Revenue-Estimate.html&quot; target=_new&gt;GLOBE NEWSWIRE&lt;/A&gt;) -- Natural Health Trends Corp. (OTCQB:NHTC) estimates revenue for the quarter ended March 31, 2014 to be &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$23.1 million. &lt;/SPAN&gt;The Company also estimates that its deferred revenue at March 31, 2014 was &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$7.9 million, compared to $2.6 million &lt;/SPAN&gt;at December 31, 2013. &amp;nbsp;In the first quarter of 2013, revenue was &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$8.7 million, with &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;deferred revenue of $1.1 million at March 31, 2013 and $836,000 at December 31, 2012.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;The revenue estimate is preliminary and has not been reviewed by the Company&apos;s independent accountants.&amp;nbsp;Significant updates and revisions may be required before the release of the Company&apos;s first quarter results in May. &amp;nbsp;In addition, the Company&apos;s quarterly financial results will include other factors necessary to calculate additional financial metrics, including gross profit and net income.&lt;/P&gt;&lt;/SPAN&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=43190</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">42668</guid><pubDate>Sun, 09 Mar 2014 05:00:00 GMT</pubDate><description>&lt;P id=PARA2560&gt;&lt;FONT size=+0&gt;&lt;A  href=&quot;http://www.sec.gov/Archives/edgar/data/912061/000143774914003670/nhtc20131231_10k.htm&quot; target=_new&gt;NATURAL HEALTH TRENDS CORP.&lt;/A&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P id=PARA2561&gt;&lt;FONT size=+0&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/P&gt;
&lt;P id=PARA2562&gt;&lt;FONT size=+0&gt;CONSOLIDATED STATEMENTS OF OPERATIONS&lt;/FONT&gt;&lt;/P&gt;
&lt;P id=PARA2563&gt;&lt;FONT size=+0&gt;(In Thousands, Except Per Share Data)&lt;/FONT&gt;&lt;/P&gt;
&lt;P id=PARA2564&gt;&lt;FONT size=+0&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/P&gt;
&lt;TABLE id=TBL2625 border=0 cellSpacing=0 cellPadding=0&gt;
&lt;TBODY&gt;
&lt;TR id=TBL2625.finRow.1&gt;
&lt;TD&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.1.lead.D3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.1.amt.D3 colSpan=6&gt;
&lt;P id=PARA2565&gt;&lt;FONT size=+0&gt;Year Ended December 31,&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.1.trail.D3&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.2&gt;
&lt;TD&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.2.lead.D2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.2.amt.D2 colSpan=2&gt;
&lt;P id=PARA2566&gt;&lt;FONT size=+0&gt;2012&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.2.trail.D2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.2.lead.D3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.2.amt.D3 colSpan=2&gt;
&lt;P id=PARA2567&gt;&lt;FONT size=+0&gt;2013&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.2.trail.D3&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.3&gt;
&lt;TD&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.3.lead.B2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.3.symb.B2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.3.amt.B2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.3.trail.B2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.3.lead.B3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.3.symb.B3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.3.amt.B3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.3.trail.B3&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.4&gt;
&lt;TD&gt;
&lt;P id=PARA2568&gt;&lt;FONT size=+0&gt;Net sales&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.4.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.4.symb.2&gt;$&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.4.amt.2&gt;37,514&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.4.trail.2 noWrap&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.4.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.4.symb.3&gt;$&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.4.amt.3&gt;52,527&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.4.trail.3 noWrap&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.5&gt;
&lt;TD&gt;
&lt;P id=PARA2571&gt;&lt;FONT size=+0&gt;Cost of sales&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.5.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.5.symb.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.5.amt.2&gt;9,685&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.5.trail.2 noWrap&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.5.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.5.symb.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.5.amt.3&gt;12,551&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.5.trail.3 noWrap&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.6&gt;
&lt;TD&gt;
&lt;P id=PARA2574&gt;&lt;FONT size=+0&gt;Gross profit&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.6.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.6.symb.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.6.amt.2&gt;27,829&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.6.trail.2 noWrap&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.6.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.6.symb.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.6.amt.3&gt;39,976&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.6.trail.3 noWrap&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.7&gt;
&lt;TD&gt;
&lt;P id=PARA2577&gt;&lt;FONT size=+0&gt;Operating expenses:&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.7.lead.B2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.7.symb.B2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.7.amt.B2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.7.trail.B2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.7.lead.B3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.7.symb.B3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.7.amt.B3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.7.trail.B3&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.8&gt;
&lt;TD&gt;
&lt;P id=PARA2578&gt;&lt;FONT size=+0&gt;Distributor commissions&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.8.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.8.symb.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.8.amt.2&gt;15,724&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.8.trail.2 noWrap&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.8.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.8.symb.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.8.amt.3&gt;24,053&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.8.trail.3 noWrap&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.9&gt;
&lt;TD&gt;
&lt;P id=PARA2581&gt;&lt;FONT size=+0&gt;Selling, general and administrative expenses (including stock-based compensation expense of $94 and $110 during 2012 and 2013, respectively)&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.9.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.9.symb.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.9.amt.2&gt;9,415&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.9.trail.2 noWrap&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.9.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.9.symb.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.9.amt.3&gt;11,634&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.9.trail.3 noWrap&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.10&gt;
&lt;TD&gt;
&lt;P id=PARA2586&gt;&lt;FONT size=+0&gt;Depreciation and amortization&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.10.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.10.symb.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.10.amt.2&gt;45&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.10.trail.2 noWrap&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.10.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.10.symb.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.10.amt.3&gt;66&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.10.trail.3 noWrap&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.11&gt;
&lt;TD&gt;
&lt;P id=PARA2589&gt;&lt;FONT size=+0&gt;Total operating expenses&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.11.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.11.symb.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.11.amt.2&gt;25,184&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.11.trail.2 noWrap&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.11.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.11.symb.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.11.amt.3&gt;35,753&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.11.trail.3 noWrap&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.12&gt;
&lt;TD&gt;
&lt;P id=PARA2592&gt;&lt;FONT size=+0&gt;Income from operations&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.12.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.12.symb.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.12.amt.2&gt;2,645&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.12.trail.2 noWrap&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.12.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.12.symb.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.12.amt.3&gt;4,223&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.12.trail.3 noWrap&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.13&gt;
&lt;TD&gt;
&lt;P id=PARA2595&gt;&lt;FONT size=+0&gt;Other expense, net&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.13.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.13.symb.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.13.amt.2&gt;(39&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.13.trail.2 noWrap&gt;)&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.13.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.13.symb.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.13.amt.3&gt;(32&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.13.trail.3 noWrap&gt;)&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.14&gt;
&lt;TD&gt;
&lt;P id=PARA2598&gt;&lt;FONT size=+0&gt;Income before income taxes&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.14.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.14.symb.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.14.amt.2&gt;2,606&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.14.trail.2 noWrap&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.14.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.14.symb.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.14.amt.3&gt;4,191&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.14.trail.3 noWrap&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.15&gt;
&lt;TD&gt;
&lt;P id=PARA2601&gt;&lt;FONT size=+0&gt;Income tax provision (benefit)&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.15.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.15.symb.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.15.amt.2&gt;(24&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.15.trail.2 noWrap&gt;)&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.15.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.15.symb.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.15.amt.3&gt;102&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.15.trail.3 noWrap&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.16&gt;
&lt;TD&gt;
&lt;P id=PARA2604&gt;&lt;FONT size=+0&gt;Net income&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.16.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.16.symb.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.16.amt.2&gt;2,630&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.16.trail.2 noWrap&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.16.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.16.symb.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.16.amt.3&gt;4,089&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.16.trail.3 noWrap&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.17&gt;
&lt;TD&gt;
&lt;P id=PARA2607&gt;&lt;FONT size=+0&gt;Preferred stock dividends&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.17.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.17.symb.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.17.amt.2&gt;(17&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.17.trail.2 noWrap&gt;)&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.17.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.17.symb.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.17.amt.3&gt;(15&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.17.trail.3 noWrap&gt;)&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.18&gt;
&lt;TD&gt;
&lt;P id=PARA2610&gt;&lt;FONT size=+0&gt;Net income available to common stockholders&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.18.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.18.symb.2&gt;$&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.18.amt.2&gt;2,613&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.18.trail.2 noWrap&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.18.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.18.symb.3&gt;$&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.18.amt.3&gt;4,074&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.18.trail.3 noWrap&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.19&gt;
&lt;TD&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.19.lead.B2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.19.symb.B2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.19.amt.B2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.19.trail.B2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.19.lead.B3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.19.symb.B3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.19.amt.B3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.19.trail.B3&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.20&gt;
&lt;TD&gt;
&lt;P id=PARA2613&gt;&lt;FONT size=+0&gt;Income per share of Natural Health Trends &amp;#8211; basic&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.20.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.20.symb.2&gt;$&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.20.amt.2&gt;0.24&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.20.trail.2 noWrap&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.20.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.20.symb.3&gt;$&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.20.amt.3&gt;0.36&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.20.trail.3 noWrap&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.21&gt;
&lt;TD&gt;
&lt;P id=PARA2616&gt;&lt;FONT size=+0&gt;Income per share of Natural Health Trends &amp;#8211; diluted&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.21.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.21.symb.2&gt;$&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.21.amt.2&gt;0.23&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.21.trail.2 noWrap&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.21.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.21.symb.3&gt;$&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.21.amt.3&gt;0.36&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.21.trail.3 noWrap&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.22&gt;
&lt;TD&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.22.lead.B2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.22.symb.B2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.22.amt.B2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.22.trail.B2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.22.lead.B3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.22.symb.B3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.22.amt.B3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.22.trail.B3&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.23&gt;
&lt;TD&gt;
&lt;P id=PARA2619&gt;&lt;FONT size=+0&gt;Weighted-average number of shares outstanding &amp;#8211; basic&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.23.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.23.symb.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.23.amt.2&gt;10,944&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.23.trail.2 noWrap&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.23.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.23.symb.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.23.amt.3&gt;11,154&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.23.trail.3 noWrap&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR id=TBL2625.finRow.24&gt;
&lt;TD&gt;
&lt;P id=PARA2622&gt;&lt;FONT size=+0&gt;Weighted-average number of shares outstanding &amp;#8211; diluted&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.24.lead.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.24.symb.2&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.24.amt.2&gt;11,234&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.24.trail.2 noWrap&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.24.lead.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.24.symb.3&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.24.amt.3&gt;11,331&lt;/TD&gt;
&lt;TD id=TBL2625.finRow.24.trail.3 noWrap&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;
&lt;P&gt;Management Discussion and Analysis&lt;/P&gt;
&lt;P&gt;Results of Operations&lt;/P&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;Net sales were $52.5 million &lt;/SPAN&gt;for the year ended December 31, 2013 &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;compared with $37.5 million &lt;/SPAN&gt;a year ago, an &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;increase &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;of $15.0 million, or 40%.&amp;nbsp;&lt;/SPAN&gt; Hong Kong net sales increased $14.4 million, or 55%, over the prior year.&amp;nbsp; The increase can be attributable to the year-long marketing campaign and in-market activities designed to reward our members with additional cash bonuses, prizes and advancement in our international recognition program, which we refer to as the Supreme Bonus program. A similar incentive program during the prior year ended in June.&lt;/P&gt;
&lt;P&gt;Outside of our Hong Kong business, &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;net sales elsewhere increased $663,000, or 6%,&lt;/SPAN&gt; compared with a year ago. A decrease in the Russian market was substantially offset by increases in Taiwan and South Korea, both of which benefited from additional sales and marketing programs offered during 2013.&lt;/P&gt;
&lt;P&gt;As of December 31, 2013, the operating subsidiaries of the Company had 27,520 active distributors, compared to 20,680 active distributors at December 31, 2012. Hong Kong experienced an increase of 6,060 active distributors, or 43%, from December 31, 2012 to December 31, 2013.&lt;/P&gt;
&lt;P&gt;As of December 31, 2013, the Company had &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;deferred revenue of $2.6 million,&lt;/SPAN&gt; of which $1.9 million pertained to unshipped product orders, $449,000 pertained to auto ship advances and $182,000 pertained to unamortized enrollment package revenue.&lt;BR&gt;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=42668</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">42034</guid><pubDate>Tue, 14 Jan 2014 05:00:00 GMT</pubDate><description>&lt;P&gt;DALLAS, Jan. 13, 2014 (&lt;A  href=&quot;http://globenewswire.com/news-release/2014/01/13/602113/10064022/en/Natural-Health-Trends-Announces-Fourth-Quarter-Revenue-Estimate.html&quot; target=_blank&gt;GLOBE NEWSWIRE&lt;/A&gt;) -- Natural Health Trends Corp. (OTCQB:NHTC) estimates revenue for the quarter ended December 31, 2013 to be &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$19.1 million. &lt;/SPAN&gt;The Company also estimates that its deferred revenue at December 31, 2013 was &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$2.6 million, compared to $1.5 million &lt;/SPAN&gt;at September 30, 2013. In the fourth quarter of 2012, revenue was &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$8.1 &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;million, with deferred revenue of $836,000&lt;/SPAN&gt; at December 31, 2012 &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;and $768,000&lt;/SPAN&gt; at September 30, 2012.&lt;/P&gt;
&lt;P&gt;The revenue estimate is preliminary and has not been reviewed by the Company&apos;s independent accountants. Significant updates and revisions may be required before the release of the Company&apos;s fourth quarter results in March. &amp;nbsp;In addition, the Company&apos;s audited financial results will include other factors necessary to calculate additional financial metrics, including gross profit and net income.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=42034</link></item><item><title>Deal Flow</title><guid isPermaLink="false">41705</guid><pubDate>Fri, 06 Dec 2013 05:00:00 GMT</pubDate><description>&lt;P&gt;&lt;FONT size=+0&gt;&lt;B&gt;NATURAL HEALTH TRENDS CORP.&lt;/B&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P id=PARA105&gt;&lt;FONT size=+0&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/P&gt;
&lt;P id=PARA106&gt;&lt;FONT size=+0&gt;&lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;1,495,952 shares of common stock issuable upon exercise of warrants&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P id=PARA107&gt;&lt;FONT size=+0&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/P&gt;
&lt;P id=PARA108&gt;&lt;FONT size=+0&gt;This prospectus relates to the sale or other disposition of up to a &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;total of 1,495,952 shares of &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;our common stock, par value $0.001,&lt;/SPAN&gt; that may be offered from time to time by the selling stockholders listed on page&lt;B&gt; &lt;/B&gt;16 or their transferees. The shares being offered by this prospectus consist of up to 1,495,952 shares issuable upon the exercise of warrants held by the selling stockholders. The warrants were&amp;nbsp;issued in a private placement financing completed in October 2007.&lt;/FONT&gt;&lt;/P&gt;
&lt;P id=PARA109&gt;&lt;FONT size=+0&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/P&gt;
&lt;P id=PARA110&gt;&lt;FONT size=+0&gt;This prospectus also covers any additional shares of common stock that may become issuable upon any anti-dilution adjustment pursuant to the terms of the above-described warrants by reason of stock splits, stock dividends, or similar events. &lt;/FONT&gt;&lt;/P&gt;
&lt;P id=PARA111&gt;&lt;FONT size=+0&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/P&gt;
&lt;P id=PARA112&gt;&lt;FONT size=+0&gt;We will receive no proceeds from the sale or other disposition of shares of our common stock by the selling stockholders.&lt;/FONT&gt; &lt;FONT size=+0&gt;However, we will receive proceeds of $3.52 per share from the exercise of any of the warrants, except to the extent that any such warrants are exercised on a cashless basis.&lt;/FONT&gt;&lt;/P&gt;
&lt;P id=PARA114&gt;&lt;FONT size=+0&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/P&gt;
&lt;P id=PARA115&gt;&lt;FONT size=+0&gt;The selling stockholders may sell or otherwise dispose of the shares of common stock covered by this prospectus in a number of different ways and at varying prices. For a description of the plan of distribution of the shares, please see page 18 of this prospectus. The selling stockholders will pay all brokerage fees and commissions and similar expenses. We will pay all expenses (except brokerage fees and commissions and similar expenses) relating to the registration of the shares with the Securities and Exchange Commission (the &amp;#8220;SEC&amp;#8221; or &amp;#8220;Commission&amp;#8221;).&lt;/FONT&gt;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=41705</link></item><item><title>13D and 13G Activity</title><guid isPermaLink="false">41666</guid><pubDate>Wed, 27 Nov 2013 05:00:00 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://www.sec.gov/Archives/edgar/data/912061/000110465913087189/a13-25068_1sc13da.htm&quot; target=_blank&gt;13D filed on 11/26/2013&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Purpose of transaction:&lt;/P&gt;
&lt;P&gt;Mr. Broady and the Trust acquired the Shares for investment purposes. Neither Mr. Broady nor the Trust have any plans or proposals with respect to any of the matters set forth in paragraphs (a) through (j) of Item 4 of Schedule 13D; provided, that Mr. Broady has served on the board of directors of the Issuer since October 17, 2008. Based on various factors such as current or anticipated trading prices for the Shares, market and industry conditions, the financial and operating condition of the Issuer, and the composition of the Issuer&amp;#8217;s board of directors, Mr. Broady and/or the Trust may acquire additional Shares or sell all or part of their Shares, in their sole discretion, in open market or private transactions without any prior notice to the Issuer. In connection with serving on the board of directors, Mr. Broady also regularly communicates with and makes suggestions to the Issuer&amp;#8217;s officers, other directors and other shareholders with respect to the Issuer, including matters involving the Issuer&amp;#8217;s operations, policies, management and board of directors composition.&lt;/P&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;Mr. Broady is deemed to beneficially own 3,615,737 Shares. Of the 3,615,737 Shares reported in this Item 5(a): &lt;/SPAN&gt;(i) 3,376,934 Shares are held directly by Mr. Broady, (ii) 61,693 Shares are issuable to Mr. Broady upon conversation of Series A Convertible Preferred Stock, (iii) 177,110 Shares are held by the Trust, of which Mr. Broady is the trustee and a beneficiary.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=41666</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">41173</guid><pubDate>Thu, 07 Nov 2013 05:00:00 GMT</pubDate><description>&lt;P&gt;&lt;STRONG&gt;&lt;A  href=&quot;http://globenewswire.com/news-release/2013/11/06/587481/10056353/en/Natural-Health-Trends-Reports-Third-Quarter-2013-Financial-Results.html&quot; target=_blank&gt;Third Quarter Financial Results&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Total revenues were &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$14.2 million, up 52% compared to $9.3 million&lt;/SPAN&gt; for the third quarter last year, and &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;up 34% &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;sequentially from the $10.6 million&lt;/SPAN&gt; for the second quarter this year. This was the third consecutive sequential quarterly increase in revenues. 
&lt;LI&gt;Net income was &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$1.3 million, or $0.12 per &lt;/SPAN&gt;diluted share, &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;compared to $747,000, or $0.07 per&lt;/SPAN&gt; diluted share last year. &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&quot;Expanded promotions, successful product launches, effective training and enhanced leadership development programs are propelling our strong sales momentum for the third quarter and on a year-to-date basis got us caught up to a more expected pace of growth,&quot; commented Chris Sharng, President of Natural Health Trends Corp. &quot;As we have indicated before, we are well positioned to deliver growth for the full year with a strong second-half of the year, and the results for the third quarter reinforce that confidence.&quot;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=41173</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">40950</guid><pubDate>Mon, 14 Oct 2013 04:00:00 GMT</pubDate><description>&lt;P&gt;DALLAS, Oct. 11, 2013 (&lt;A  href=&quot;http://globenewswire.com/news-release/2013/10/11/580002/10052340/en/Natural-Health-Trends-Announces-Third-Quarter-Revenue-Estimate.html&quot; target=_blank&gt;GLOBE NEWSWIRE&lt;/A&gt;) -- Natural Health Trends Corp. (OTCQB:NHTC) estimates revenue for the quarter ended September 30, 2013 to be &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$14.2 million.&lt;/SPAN&gt; The Company also estimates that its deferred revenue at September 30, 2013 was &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$1.5 million, compared to $1.1 &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;million &lt;/SPAN&gt;at June 30, 2013. In the third quarter of 2012, revenue was &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$9.3 million, with deferred revenue of $768,000 &lt;/SPAN&gt;at September 30, 2012 and &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$1.6 million&lt;/SPAN&gt; at June 30, 2012.&lt;/P&gt;
&lt;P&gt;The revenue estimate is preliminary and has not been reviewed by the Company&apos;s independent accountants. Significant updates and revisions may be required before the release of the Company&apos;s third quarter results in November. In addition, the Company&apos;s quarterly financial results will include other factors necessary to calculate additional financial metrics, including gross profit and net income.&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=40950</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">40129</guid><pubDate>Wed, 07 Aug 2013 04:00:00 GMT</pubDate><description>&lt;P&gt;&lt;STRONG&gt;&lt;A  href=&quot;http://www.globenewswire.com/news-release/2013/08/06/564959/10043613/en/Natural-Health-Trends-Reports-Second-Quarter-2013-Financial-Results.html&quot; target=_blank&gt;Second Quarter 2013 Financial Results&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Total revenues were &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$10.6 million compared to $11.0 million&lt;/SPAN&gt; in the second quarter last year, and up sequentially from the&lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;&amp;nbsp;$8.7 million&lt;/SPAN&gt; in the first quarter. This was the second consecutive sequential quarterly increase in revenues. The year-over-year decrease in revenues for the second quarter reflects a change in the Company&apos;s promotional plans, which deploy a full-year cash incentive this year, while last year&apos;s comparable campaign ended at the end of June. Additionally, a price increase in Hong Kong for Premium Noni Juice&amp;#65533; may have accelerated orders into the second quarter last year. 
&lt;LI&gt;Operating income was &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$948,000, an increase of 7% compared to $889,000&lt;/SPAN&gt; last year. 
&lt;LI&gt;Net income was &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$904,000, or $0.08 per&lt;/SPAN&gt; diluted share, compared to &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$846,000, or $0.08 per &lt;/SPAN&gt;diluted share last year. &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&quot;We are excited to have kept pace with an exceptional first half of 2012, which was a huge 62% increase over 2011, and we have delivered multiple consecutive quarters of sequential revenue increases,&quot; said Chris Sharng, President of Natural Health Trends Corp. &quot;We are well positioned to deliver a strong second-half of the year.&quot;&lt;/P&gt;
&lt;P&gt;&quot;We continue to place great emphasis on our product offering, rolling out new products and supporting our existing lines,&quot; Mr. Sharng continued. &quot;This quarter we were pleased to announce exclusive multi-level marketing distribution rights for one of our top selling products, Alura by NHT Global. The exclusive arrangement states that we are the sole organization in our industry with the right to offer Alura&apos;s proprietary, patented formula under any brand name. To support this announcement to the field, Dr. Ronald J. Thompson will be a featured guest at many of our upcoming events and trainings held in our markets around the world. These activities, and the many others we have planned for the remainder of the year, provide avenues for member growth, opportunities for learning and sharing, and give our established leaders tools they need to succeed.&quot;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=40129</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">38985</guid><pubDate>Thu, 09 May 2013 04:00:00 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://www.nasdaq.com/article/natural-health-trends-reports-first-quarter-2013-financial-results-20130508-01250&quot; target=_blank&gt;First Quarter Financial Highlights&lt;/A&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Total revenues were &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$8.7 million compared to $9.1 million &lt;/SPAN&gt;in the first quarter last year and &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$8.1 million&lt;/SPAN&gt; in the fourth quarter of 2012. The year-over-year decrease in revenues for the first quarter reflects a change in the Company&apos;s promotional plans. In 2013, a cash promotion in Greater China runs through the entire year. In 2012, the comparable cash promotion ended at June 30th. 
&lt;LI&gt;Net income available to common stockholders of Natural Health Trends was &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$283,000, or $0.03 per &lt;/SPAN&gt;diluted share, compared to net income of &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$503,000, or $0.04 per &lt;/SPAN&gt;diluted share last year. &lt;/LI&gt;&lt;/UL&gt;&quot;We are pleased with our members&apos; enthusiastic response to our marketing plans in this new year,&quot; commented Chris Sharng, President of Natural Health Trends Corp. &quot;The events in Macau and St. Petersburg respectively staged for our Greater China and Commonwealth of Independent States markets were both very successful. Our sales are keeping pace with a very strong first half a year ago. Thus far, 2013 has been a year of exceptional activity, as we focus on leveraging our established leaders with new promotions, robust training, and additional products to drive growth.&quot;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=38985</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">38628</guid><pubDate>Mon, 15 Apr 2013 04:00:00 GMT</pubDate><description>&lt;SPAN itemprop=&quot;articleBody&quot;&gt;
&lt;P&gt;DALLAS, April 15, 2013 (&lt;A  href=&quot;http://www.globenewswire.com/news-release/2013/04/15/538387/10028482/en/Natural-Health-Trends-Announces-First-Quarter-Revenue-Estimate.html&quot; target=_blank&gt;GLOBE NEWSWIRE&lt;/A&gt;) -- Natural Health Trends Corp. (OTCQB:NHTC) today provided a preliminary outlook for its first quarter financial results, the period ended March 31, 2013. The Company estimates revenue for the quarter to be $8.7 million. The Company also estimates that its deferred revenue, consisting of unshipped product and unamortized enrollment fees, at March 31, 2013 was $1.1 million, compared to $836,000 at December 31, 2012. In the first quarter of 2012, revenue was $9.1 million, with deferred revenue of $1.3 million at March 31, 2012 and $967,000 at December 31, 2011.&lt;/P&gt;
&lt;P&gt;These results are preliminary and have not been reviewed by the Company&apos;s independent accountants. Significant updates and revisions may be required before the release of the Company&apos;s first quarter results in May.&lt;/P&gt;&lt;/SPAN&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=38628</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">37379</guid><pubDate>Wed, 15 Aug 2012 04:00:00 GMT</pubDate><description>&lt;P&gt;&lt;A  href=&quot;http://www.globenewswire.com/newsroom/news.html?d=10001836&quot; target=_blank&gt;Second Quarter 2012 Results&lt;/A&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;In the second quarter, sales, at $11.0 million, were up 52% over a year ago. 
&lt;LI&gt;Second quarter earnings per share were $0.08, a 33% increase over the comparable period in 2011.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&quot;Our rewarding business model that is centered around dedicated field leaders, an enhanced commission structure, systemic training, dedicated support and services, effective promotions and high-quality products offers an ideal opportunity for personal success for our members,&quot; said Chris Sharng, President of Natural Health Trends. &quot;We believe it&apos;s our continued focus on these core areas of our business that is driving our business growth. We are pleased with the results and will continue building upon our success.&quot;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=37379</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">35515</guid><pubDate>Sun, 15 Jul 2012 04:00:00 GMT</pubDate><description>&lt;P&gt;DALLAS, TX, July 13, 2012 -- Natural Health Trends Corp. (OTCQB: NHTC) &lt;A  href=&quot;http://www.sec.gov/Archives/edgar/data/912061/000143774912006925/ex99-1.htm&quot; target=_blank&gt;announced today&lt;/A&gt; that its estimated revenue for the quarter ended June 30, 2012 was &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$11.0 million, a 52% increase over the comparable period a year ago&lt;/SPAN&gt;. The Company also estimates that its deferred revenue, consisting of unshipped product and unamortized enrollment fees, at June 30, 2012 was $1.6 million, compared to $1.3 million at March 31, 2012. In the second quarter of 2011, revenue was $7.2 million, with deferred revenue of $2.7 million at June 30, 2011 and $1.6 million at March 31, 2011. The increase year-on-year was largely due to the Hong Kong market. &lt;/P&gt;
&lt;P&gt;For the six months ended June 30, 2012, estimated revenue is $20.1 million, a 62% increase over the comparable period in the prior year. &lt;/P&gt;
&lt;P&gt;These results are preliminary and have not been reviewed by the Company&amp;#8217;s independent accountants. Significant updates and revisions may be required before the release of our first quarter results in August. &lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=35515</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">34726</guid><pubDate>Sun, 13 May 2012 04:00:00 GMT</pubDate><description>&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=center&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;NATURAL HEALTH TRENDS CORP.&lt;/FONT&gt;&lt;/DIV&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block&quot;&gt;&lt;BR&gt;&lt;/DIV&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=center&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)&lt;/FONT&gt;&lt;/DIV&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=center&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;(In Thousands, Except Per Share Data)&lt;/FONT&gt;&lt;/DIV&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block&quot;&gt;&lt;BR&gt;&lt;/DIV&gt;
&lt;DIV align=left&gt;
&lt;TABLE style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot; cellSpacing=0 cellPadding=0 width=&quot;100%&quot;&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp; &lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid&quot; vAlign=bottom colSpan=6&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=center&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;A  href=&quot;http://www.sec.gov/Archives/edgar/data/912061/000143774912004821/0001437749-12-004821-index.htm&quot; target=_blank&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=center&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Three Months Ended March 31,&lt;/FONT&gt;&lt;/DIV&gt;&lt;/A&gt;&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp; &lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid&quot; vAlign=bottom colSpan=2&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=center&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid&quot; vAlign=bottom colSpan=2&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=center&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2012&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign=bottom&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp; &lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom colSpan=2&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom colSpan=2&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net sales&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;5,175&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;9,090&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=white&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Cost of sales&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,529&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2,399&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Gross profit&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;3,646&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;6,691&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=white&gt;
&lt;TD vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Operating expenses:&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Distributor commissions&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,762&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;3,691&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=white&gt;
&lt;TD vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Selling, general and administrative expenses (including stock-based compensation expense of $14 and $20 during the three months ended March 31, 2011 and 2012, respectively)&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2,030&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2,437&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Depreciation and amortization&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;232&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;12&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=white&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total operating expenses&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;4,024&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;6,140&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Income (loss) from operations&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(378&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;551&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=white&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Other expense, net&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(95&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(63&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Income (loss) before income taxes&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(473&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;488&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=white&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Income tax provision (benefit)&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;7&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(19&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net income (loss)&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(480&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;507&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=white&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Plus:&amp;nbsp;&amp;nbsp;Net loss attributable to the noncontrolling interest&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;8&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#8211;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net income (loss) attributable to Natural Health Trends&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(472&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;507&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=white&gt;
&lt;TD vAlign=bottom width=&quot;70%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp; &lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Preferred stock dividends&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(4&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(4&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=white&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net income (loss) attributable to common stockholders of Natural Health Trends&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(476&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;503&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD vAlign=bottom width=&quot;70%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp; &lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=white&gt;
&lt;TD vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Income (loss) per share of Natural Health Trends:&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Basic&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.04&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.05&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=white&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Diluted&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.04&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.04&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD vAlign=bottom width=&quot;70%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp; &lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=white&gt;
&lt;TD vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted-average number of shares outstanding:&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Basic&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;10,635&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;10,863&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=white&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;70%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Diluted&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;10,635&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;12%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;11,181&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/DIV&gt;&lt;/FONT&gt;&lt;/DIV&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;&lt;/FONT&gt;&amp;nbsp;&lt;/DIV&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The following table sets forth revenue by market for the periods indicated (in thousands):&lt;/FONT&gt;&lt;/DIV&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block&quot;&gt;&lt;BR&gt;&lt;/DIV&gt;
&lt;DIV align=left&gt;
&lt;TABLE style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot; cellSpacing=0 cellPadding=0 width=&quot;100%&quot;&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;48%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp; &lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid&quot; vAlign=bottom width=&quot;50%&quot; colSpan=14&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=center&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Three Months Ended March 31,&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;48%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp; &lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid&quot; vAlign=bottom width=&quot;24%&quot; colSpan=6&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=center&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid&quot; vAlign=bottom width=&quot;24%&quot; colSpan=6&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=center&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2012&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign=bottom width=&quot;48%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp; &lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;11%&quot; colSpan=2&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;11%&quot; colSpan=2&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;11%&quot; colSpan=2&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;11%&quot; colSpan=2&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD vAlign=bottom width=&quot;48%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;North America&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;297&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;5.8&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;435&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;4.8&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=white&gt;
&lt;TD vAlign=bottom width=&quot;48%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Hong Kong&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2,376&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;45.9&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;6,126&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;67.4&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD vAlign=bottom width=&quot;48%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;China&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;286&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;5.5&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;215&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.4&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=white&gt;
&lt;TD vAlign=bottom width=&quot;48%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Taiwan&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;659&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;12.7&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;499&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;5.5&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD vAlign=bottom width=&quot;48%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;South Korea&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;110&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.1&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;114&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.2&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=white&gt;
&lt;TD vAlign=bottom width=&quot;48%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Japan&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;75&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.5&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;45&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.5&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD vAlign=bottom width=&quot;48%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Russia&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,268&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;24.5&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,573&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;17.3&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=white&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;48%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Europe&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;104&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.0&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;83&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.9&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR bgColor=#c0ffff&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;48%&quot; align=left&gt;
&lt;DIV style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=left&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&lt;/FONT&gt;&lt;/DIV&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;5,175&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;100.0&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;9,090&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; align=right&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot; vAlign=bottom width=&quot;1%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot; vAlign=bottom width=&quot;10%&quot;&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;100.0&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot; vAlign=bottom width=&quot;1%&quot; noWrap&gt;&lt;FONT style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/FONT&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/DIV&gt;
&lt;P&gt;Net sales were &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$9.1 million &lt;/SPAN&gt;for the three months ended March 31, 2012 compared with &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$5.2 &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;million &lt;/SPAN&gt;for the comparable period a year ago, an &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;increase of $3.9 million, or 76%.&lt;/SPAN&gt; Hong Kong net sales &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;increased $3.8 million, or 158%&lt;/SPAN&gt;, over the comparable period a year ago. The increase in Hong Kong was largely due to a successful marketing event held in Macau in January 2012, and even moreso, due to new incentive programs launched at the beginning of the year surrounding our recognition program. These programs are expected to last at least until the end of the second quarter of 2012. In 2011, the Company&apos;s 10th Anniversary celebration in Hong Kong may have deferred or pulled forward more orders into the late second and early third quarters. For year-on-year evaluation, &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;we believe that a year-to-date comparison with the comparable periods a year ago through June and September may be more indicative of our business trend&lt;/SPAN&gt;. &lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=34726</link></item><item><title>Liquidity Requirements</title><guid isPermaLink="false">34713</guid><pubDate>Thu, 29 Mar 2012 04:00:00 GMT</pubDate><description>&lt;P&gt;The Company believes that its existing internal liquidity, supported by cash on hand and cash flows from operations &lt;A  href=&quot;http://www.sec.gov/Archives/edgar/data/912061/000143774912002813/0001437749-12-002813-index.htm&quot; target=_blank&gt;should be adequate&lt;/A&gt; to fund normal business operations and address its financial commitments for at least the next 12 months, assuming no significant unforeseen expense or further revenue decline.&lt;/P&gt;
&lt;P&gt;The Company does not have any significant unused sources of liquid assets. Potentially the Company might receive additional external funding if currently outstanding warrants are exercised. Furthermore, if necessary, the Company may attempt to generate more funding from the capital markets, but currently does not believe that will be necessary. &lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=34713</link></item><item><title>Comments &amp; Business Outlook </title><guid isPermaLink="false">33629</guid><pubDate>Thu, 16 Feb 2012 05:00:00 GMT</pubDate><description>&lt;P&gt;We will begin tracking the the NHTC story to determine if its restructuring efforts have staying power:&lt;/P&gt;
&lt;P&gt;&lt;A  href=&quot;http://www.sec.gov/Archives/edgar/data/912061/000143774911008628/ex99-1.htm&quot; target=_blank&gt;DALLAS, TX, November 14, 2011&amp;nbsp;&lt;/A&gt;-- Natural Health Trends Corp. (Pink Sheets: NHTC) announced today that it has filed with the Securities and Exchange Commission periodic reports covering periods ended after September 30, 2009, including a comprehensive Annual Report on Form 10-K for each of the fiscal years ended December 31, 2009 and 2010 (in lieu of filing separate reports for each of those years), and separate Quarterly Reports on Form 10-Q for each of the quarters ended March 31, 2011 through September 30, 2011.&amp;nbsp; The Company does not intend to file separate Quarterly Reports on Form 10-Q for any of the quarters ended March 31, 2010 through September 30, 2010, because that information is included in the comprehensive Annual Report.&lt;BR&gt;&amp;nbsp;&lt;BR&gt;Focusing on its most recent results, the Company announced &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;$1.8 million of net income, or $0.17 income per share, on $22.9 million of sales &lt;/SPAN&gt;during the first nine months of 2011, compared to $&lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;2.1 million of net loss, or $0.20 loss per share, on $17.4 million &lt;/SPAN&gt;during the comparable period in 2010.&amp;nbsp;&amp;nbsp; Year on year sales &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;increased 32%&lt;/SPAN&gt;, while selling, general and administrative expenses &lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;decreased 15%&lt;/SPAN&gt;.&lt;BR&gt;&amp;nbsp;&lt;BR&gt;Chris Sharng, president of Natural Health Trends, said, &amp;#8220;In the last two years, we have completely changed our culture and re-built a competitive business model based on dedicated field leaders, enhanced commission structure, systemic training, attentive services, effective promotions and high-quality products.&amp;nbsp; Our operating costs are way down after aggressive restructuring and will enable us to benefit from revived revenue, particularly in Greater China.&amp;#8221; &lt;BR&gt;&amp;nbsp;&lt;BR&gt;&amp;#8220;The third quarter&amp;#8217;s results were bolstered by our 10th anniversary celebration and shipments of orders received in the prior quarter.&amp;nbsp;&lt;SPAN style=&quot;FONT-WEIGHT: bold&quot;&gt;&amp;nbsp;Our business is still expected to be significantly influenced by seasonality factors, such as the Chinese New Year, the Chinese Golden Week (in early October) and the summertime.&amp;nbsp;&lt;/SPAN&gt; The cash we generate will have to be re-invested in the business to support existing operations and pursue opportunities we have in our markets.&amp;#8221;&lt;BR&gt;&lt;/P&gt;</description><link>/companies/nhtc_natural_health_trends_corp____c/research&amp;item=33629</link></item>
            
	
	</channel>  
	
</rss>
